var title_f26_15_26864="Grasping prongs of applicator";
var content_f26_15_26864=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F73220&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F73220&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Applicator for tubal band for sterilization",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 262px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Distal end of tubal ring applicator showing grasping prongs.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_15_26864=[""].join("\n");
var outline_f26_15_26864=null;
var title_f26_15_26865="T exercise for scapular stabilizers with resistance";
var content_f26_15_26865=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F86592&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F86592&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 535px\">",
"   <div class=\"ttl\">",
"    \"T\" exercise for scapular stabilizers with resistance",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 515px; height: 189px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    \"T\" exercises are performed keeping the elbows extended. Raise your arms straight to the side (combination of shoulder extension and abduction) until they are perpendicular to and in the same plane as the torso. Hold the position for one second, and then, slowly return the arms to the starting position.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Craig Parsons, MS, PT and the Physical Therapy Network.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_15_26865=[""].join("\n");
var outline_f26_15_26865=null;
var title_f26_15_26866="Cushings disease CT";
var content_f26_15_26866=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F64273&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F64273&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    CT scan in Cushing's disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 433px; height: 334px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Coronal CT image of the sella in a 59-year-old man with Cushing's disease. No lesion is visible within the sella (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reprinted with permission from Williams Textbook of Endocrinology, 8th ed, Foster, DW, Wilson, JD (Eds), WB Saunders, Philadelphia, 1996.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_15_26866=[""].join("\n");
var outline_f26_15_26866=null;
var title_f26_15_26867="Terconazole: Drug information";
var content_f26_15_26867=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Terconazole: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?39/34/40483?source=see_link\">",
"    see \"Terconazole: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F225766\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Terazol&reg; 3;",
"     </li>",
"     <li>",
"      Terazol&reg; 7",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F225767\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Terazol&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F225789\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antifungal Agent, Vaginal",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F225769\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Vulvovaginal candidiasis:",
"     </b>",
"     Intravaginal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Terazol&reg; 3 (0.8%) vaginal cream:",
"     </i>",
"     Insert 1 applicatorful intravaginally at bedtime for 3 consecutive days.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Terazol&reg; 7 (0.4%) vaginal cream:",
"     </i>",
"     Insert 1 applicatorful intravaginally at bedtime for 7 consecutive days.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Terazol&reg; 3 vaginal suppository:",
"     </i>",
"     Insert 1 suppository intravaginally at bedtime for 3 consecutive days.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F225770\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F225752\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream, vaginal: 0.4% (45 g); 0.8% (20 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Terazol&reg; 7: 0.4% (45 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Terazol&reg; 3: 0.8% (20 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Suppository, vaginal: 80 mg (3s)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Terazol&reg; 3: 80 mg (3s) [contains coconut oil (may have trace amounts), palm kernel oil (may have trace amounts)]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F225739\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F13161314\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaginal cream: Use applicator provided by manufacturer. Insertion should be as far as possible into the vagina without causing discomfort. Wash applicator after each use; allow to dry thoroughly before putting back together.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaginal suppository: Remove foil package prior to use. Insertion should be as far as possible into the vagina without causing discomfort. If the provided applicator is used for insertion, wash and dry thoroughly prior to additional use.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F225755\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Local treatment of vulvovaginal candidiasis",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F225795\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Terconazole may be confused with tioconazole",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Terazol [U.S., Canada] may be confused with Theradol brand name for tramadol [Netherlands]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F225787\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%: Central nervous system: Headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Chills, fever, pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Dysmenorrhea; vulvar/vaginal burning, irritation, or itching",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Burning or itching of penis of sexual partner, flu-like syndrome",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F225758\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to terconazole or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F225743\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Irritation: If irritation or sensitization occurs, discontinue use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Petrolatum-based: Petrolatum-based vaginal products may damage rubber or latex condoms or diaphragms; separate use by 3 days.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Lack of response: Microbiological studies (KOH smear and/or cultures) should be repeated in patients not responding to terconazole in order to confirm the diagnosis and rule out other pathogens.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300115\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F225747\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F225749\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13161302\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Following vaginal administration, terconazole is absorbed systemically; use should be avoided during the first trimester of pregnancy.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F225772\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F225760\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cream",
"     </b>",
"     (Terazol 3 Vaginal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.8% (20 g): $52.79",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cream",
"     </b>",
"     (Terazol 7 Vaginal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.4% (45 g): $52.79",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cream",
"     </b>",
"     (Terconazole Vaginal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.4% (45 g): $43.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.8% (20 g): $40.75",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Cream",
"     </b>",
"     (Zazole Vaginal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.4% (45 g): $46.44",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.8% (20 g): $50.84",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suppository",
"     </b>",
"     (Terazol 3 Vaginal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     80 mg (3): $52.79",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suppository",
"     </b>",
"     (Terconazole Vaginal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     80 mg (3): $48.94",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F225761\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Fungistat (CO, MX, VE);",
"     </li>",
"     <li>",
"      Fungistat 3 (BB, BM, BS, BZ, GY, JM, PR, SR, TT);",
"     </li>",
"     <li>",
"      Gyno-Fungix (AR, BR);",
"     </li>",
"     <li>",
"      Gyno-Terazol (BE, CH, CZ, LU, NL, PL);",
"     </li>",
"     <li>",
"      Terazol (DK, FI);",
"     </li>",
"     <li>",
"      Terconal (IT);",
"     </li>",
"     <li>",
"      Terconer (TW)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F225742\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Triazole ketal antifungal agent; involves inhibition of fungal cytochrome P450. Specifically, terconazole inhibits cytochrome P450-dependent 14-alpha-demethylase which results in accumulation of membrane disturbing 14-alpha-demethylsterols and ergosterol depletion.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F225757\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Absorption: Extent of systemic absorption after vaginal administration may be dependent on presence of a uterus; 5% to 8% in women who had a hysterectomy versus 12% to 16% in nonhysterectomy women",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), \"Sexually Transmitted Diseases Treatment Guidelines, 2010,\"",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2010, 59(RR-12):1-110.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/15/26867/abstract-text/21160459/pubmed\" id=\"21160459\" target=\"_blank\">",
"        21160459",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9978 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-EE7AE732F8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_15_26867=[""].join("\n");
var outline_f26_15_26867=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F225766\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F225767\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F225789\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F225769\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F225770\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F225752\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F225739\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13161314\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F225755\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F225795\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F225787\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F225758\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F225743\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300115\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F225747\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F225749\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13161302\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F225772\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F225760\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F225761\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F225742\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F225757\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9978\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9978|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?39/34/40483?source=related_link\">",
"      Terconazole: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_15_26868="Why Kt/V and creatinine clearance may not correlate in continuous peritoneal dialysis";
var content_f26_15_26868=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Why Kt/V and creatinine clearance may not correlate in continuous peritoneal dialysis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/15/26868/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/15/26868/contributors\">",
"     John M Burkart, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/15/26868/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/15/26868/contributors\">",
"     Thomas A Golper, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/15/26868/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/15/26868/contributors\">",
"     Alice M Sheridan, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/15/26868/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 1, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dialysis adequacy is an important issue for patients treated with maintenance hemodialysis or peritoneal dialysis (PD). Previously, based on observational studies, most investigators agreed that calculation of both the weekly",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    and the peritoneal creatinine clearance (CCr) could be used to assess dialysis adequacy. It was therefore proposed in the 2000",
"    <span class=\"nowrap\">",
"     NKF-K/DOQI",
"    </span>",
"    guidelines that adequate dialysis required either a total weekly",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    of &gt;2.0,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a total weekly creatinine clearance of at least 60 L per week per 1.73 m2 body surface area [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26868/abstract/1-4\">",
"     1-4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, based on prospective randomized clinical trials, the 2006",
"    <span class=\"nowrap\">",
"     NKF-K/DOQI",
"    </span>",
"    guidelines recommend using",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    urea as the \"yardstick\" for dialysis dose and see no additional benefit to using both",
"    <span class=\"nowrap\">",
"     Kt/Vurea",
"    </span>",
"    and creatinine clearance to monitor dialysis dose [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26868/abstract/5\">",
"     5",
"    </a>",
"    ]. They therefore recommend that a total solute clearance target should only be in terms of",
"    <span class=\"nowrap\">",
"     Kt/Vurea.",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/58/1962?source=see_link\">",
"     \"Adequacy of peritoneal dialysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, in the text and in the clinical practice recommendation section, it is noted that knowledge of weekly creatinine clearance may be helpful for other reasons. Although these two yardsticks of solute clearance usually correlate, the values are not uncommonly discrepant [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26868/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. In some cases, for example, the",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    appears adequate, the CCr does not, and the patient seems malnourished. Other patients are gaining weight and eating well, but the clearance parameters are below target.",
"   </p>",
"   <p>",
"    How can one explain these findings? This issue, beginning with a review of the basis for solute clearance in PD, will be addressed in this topic review.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SOLUTE CLEARANCE IN PERITONEAL DIALYSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;As in any form of renal replacement therapy, total solute removal consists of the removal of the solute in question by both dialysis and residual renal clearance. In contrast to standard practice for center hemodialysis where typically only the dialysis clearance of a solute is used to measure adequacy of dialysis, in peritoneal dialysis it is standard to use total (both residual kidney and peritoneal) solute removal (clearance) as a yardstick for adequacy of dialysis. The latter reflects the balance between glomerular filtration and tubular secretion and reabsorption. Both creatinine and urea are freely filtered; however, proximal tubular secretion further increases the creatinine clearance, while tubular reabsorption of urea decreases the urea clearance. Thus, the residual creatinine clearance is an overestimate and the urea clearance is an underestimate of the glomerular filtration rate. Therefore, the glomerular filtration rate in advanced renal failure is often estimated from the mean of the two clearances. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/23/35190?source=see_link\">",
"     \"Calculation of the creatinine clearance\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In contrast, peritoneal clearance is predominantly diffusion driven; there is also a smaller component of convective clearance due to ultrafiltration. Since urea is a smaller molecule than creatinine, the peritoneal clearance of urea tends to be greater than that of creatinine; this effect is most pronounced in patients who are low transporters.",
"   </p>",
"   <p>",
"    The relation between total urea clearance and creatinine clearance reflects the sum of the renal and dialysis clearances.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The ratio of",
"      <span class=\"nowrap\">",
"       CCr-to-Kt/V",
"      </span>",
"      (reference value is",
"      <span class=\"nowrap\">",
"       60/2.0",
"      </span>",
"      = 30) tends to be higher with significant residual renal function, which often is the case when dialysis is initiated.",
"     </li>",
"     <li>",
"      The ratio of",
"      <span class=\"nowrap\">",
"       CCr-to-Kt/V",
"      </span>",
"      falls as the patient becomes anuric.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These differences are illustrated in Figure 1 from the CANUSA data which shows total solute clearance as both",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    and CCr over time (",
"    <a class=\"graphic graphic_figure graphicRef71878 \" href=\"UTD.htm?43/39/44670\">",
"     figure 1",
"    </a>",
"    ). In this study, creatinine clearance from residual renal function fell from 3.9 to 1.4",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    by two years. At the latter value (1.4",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    equals 14",
"    <span class=\"nowrap\">",
"     L/week),",
"    </span>",
"    residual renal function continued to account for 23 percent of total creatinine clearance [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26868/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Peritoneal membrane transport",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peritoneal membrane transport characteristics can also affect the relative clearances of various solutes. As mentioned above, the diffusive clearance for urea is relatively greater than that for creatinine. Thus for shorter dwells, the urea clearance per dwell tends to exceed that for creatinine.",
"   </p>",
"   <p>",
"    This is most pronounced in low transporters in whom the ratio of",
"    <span class=\"nowrap\">",
"     CCr-to-Kt/V",
"    </span>",
"    is typically lower than in high (rapid) transporters. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/23/36215?source=see_link\">",
"     \"Rapid transporters on maintenance peritoneal dialysis\"",
"    </a>",
"    .) During the typical dwells associated with CAPD, the dialysate to plasma ratio",
"    <span class=\"nowrap\">",
"     (D/P)",
"    </span>",
"    for urea tends to be near unity (equilibration between blood and dialysate) in all patients, whereas the",
"    <span class=\"nowrap\">",
"     D/P",
"    </span>",
"    for creatinine may approach unity only in high transporters (",
"    <a class=\"graphic graphic_figure graphicRef62604 \" href=\"UTD.htm?6/26/6574\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The net effect is that the weekly",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    in",
"    <span class=\"nowrap\">",
"     CAPD/CCPD",
"    </span>",
"    patients is relatively independent of transporter type while the weekly creatinine clearance falls progressively from high to low transporters (",
"    <a class=\"graphic graphic_figure graphicRef56884 \" href=\"UTD.htm?37/32/38413\">",
"     figure 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26868/abstract/2,9\">",
"     2,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These relationships were illustrated in a study of 309 CAPD patients who were anuric [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26868/abstract/10\">",
"     10",
"    </a>",
"    ]. The",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    and the CCr were correlated to each other and with the peritoneal solute transport characteristics [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26868/abstract/10\">",
"     10",
"    </a>",
"    ]. Weekly",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    values for urea were similar in the low, low-average, high-average, and high transport groups: 1.74, 1.66, 1.68, and 1.73, respectively. By comparison, the ratios of (non-normalized) peritoneal creatinine to peritoneal urea clearance in the low, low-average, high-average, and high transport groups were 0.65, 0.76, 0.84, and 0.91, respectively.",
"   </p>",
"   <p>",
"    It is important to be aware of individual patients&rsquo; peritoneal membrane transport characteristics when writing the PD prescription and interpreting solute clearance results. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/58/1962?source=see_link\">",
"     \"Adequacy of peritoneal dialysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Effect of volume of distribution",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is important to recognize the effect \"normalization\" has on these values. The urea clearance (Kt) and the creatinine clearance are normalized by V (volume of distribution) and 1.73 m2, respectively. The effect of the patient's weight on this normalization is greater for",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    than it is for creatinine clearance. This becomes most pronounced in malnourished and obese patients. If V is derived from the Watson formula [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26868/abstract/11\">",
"     11",
"    </a>",
"    ] and body surface area (BSA) from the Dubois formula [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26868/abstract/12\">",
"     12",
"    </a>",
"    ], the calculations are as follows:",
"   </p>",
"   <p>",
"    &nbsp;V (L, male) &nbsp;= &nbsp;2.447 &nbsp;+ &nbsp;(0.3362 &nbsp;x &nbsp;wt [kg]) &nbsp;+ &nbsp;(0.1074 &nbsp;x &nbsp;Ht [cm]) &nbsp;- &nbsp;(0.09516 &nbsp;x &nbsp;age [years])",
"   </p>",
"   <p>",
"    &nbsp;V (L, female) &nbsp;= &nbsp;-2.097 &nbsp;+ &nbsp;(0.2466 &nbsp;x &nbsp;wt [kg]) &nbsp;+ &nbsp;(0.1069 x Ht [cm])",
"   </p>",
"   <p>",
"    &nbsp;BSA &nbsp;= &nbsp;0.007184 &nbsp;x &nbsp;body wt [kg](0.425) &nbsp;x &nbsp;ht [cm](0.725)",
"   </p>",
"   <p>",
"    In the BSA calculation, the numbers 0.425 and 0.725 represent the exponential power of the body weight and height, respectively",
"   </p>",
"   <p>",
"    It can be appreciated from these equations that weight has a relatively greater impact on the value for V than for BSA. This is nicely illustrated in Figure 4 which compares",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    and creatinine clearance values for anuric males and females on 8 liters of therapy per day (",
"    <a class=\"graphic graphic_figure graphicRef81472 \" href=\"UTD.htm?22/22/22894\">",
"     figure 4",
"    </a>",
"    ). The",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    is higher in females compared to males, while there is little difference in the weekly creatinine clearance.",
"   </p>",
"   <p>",
"    The effect of normalization also varies with the state of nutrition. In malnourished patients, the decrease in weight causes a decrease in V, while Kt is unchanged; thus, the",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    will tend to increase. This is one reason why one often finds a",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    value that is near or above target in malnourished patients. If, in this setting, the desired body weight was used in the calculation, the",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    would not be as close to target as when actual weights are used (",
"    <a class=\"graphic graphic_table graphicRef78283 \" href=\"UTD.htm?5/22/5484\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The situation is reversed in obese patients. In obese patients who are eating well, feeling well, and have normal serum albumin concentrations, using the actual weight in the calculation often results in what appears to be low",
"    <span class=\"nowrap\">",
"     Kt/V",
"    </span>",
"    and CCr values; substituting the desired weight results in clearance values more predictive of their nutritional status (",
"    <a class=\"graphic graphic_table graphicRef78283 \" href=\"UTD.htm?5/22/5484\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18390890\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The best yardstick for adequacy of peritoneal dialysis remains to be determined. Whereas previous recommendations suggested the use of either urea or creatinine kinetics, the 2006",
"      <span class=\"nowrap\">",
"       NKF-K/DOQI",
"      </span>",
"      guidelines recommend using a",
"      <span class=\"nowrap\">",
"       Kt/Vurea",
"      </span>",
"      target (ie, urea kinetics) only. Although creatinine clearance and",
"      <span class=\"nowrap\">",
"       Kt/V",
"      </span>",
"      usually correlate, they are not infrequently discrepant. It is important to understand how these solute clearance calculations are obtained so one can interpret clinical data appropriately. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Both dialysis and residual renal function contribute in varying amounts and differently to both creatinine clearance and",
"      <span class=\"nowrap\">",
"       Kt/V.",
"      </span>",
"      The ratio of creatinine",
"      <span class=\"nowrap\">",
"       clearance-to-Kt/V",
"      </span>",
"      is higher in patients with significant residual renal function and falls as the patient becomes anuric. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Solute clearance in peritoneal dialysis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Peritoneal membrane transport characteristics may affect the relationship between creatinine clearance and",
"      <span class=\"nowrap\">",
"       Kt/V.",
"      </span>",
"      For shorter dwells, especially in low transporters on automated peritoneal dialysis therapies, the urea clearance per dwell exceeds that for creatinine. Whereas the weekly",
"      <span class=\"nowrap\">",
"       Kt/V",
"      </span>",
"      is independent of transporter type, the weekly creatinine clearance falls progressively from high to low transporters. It is important to be aware of peritoneal membrane transport characteristics of individual patients when writing the PD prescription and interpreting solute clearance results. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Peritoneal membrane transport'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patient weight has a greater effect on",
"      <span class=\"nowrap\">",
"       Kt/V",
"      </span>",
"      than on creatinine clearance. A decrease or increase in weight causes the",
"      <span class=\"nowrap\">",
"       Kt/V",
"      </span>",
"      to increase or decrease, respectively. As a result of this relationship, the",
"      <span class=\"nowrap\">",
"       Kt/V",
"      </span>",
"      is often at or above target values in malnourished patients and low in obese patients. Using the desired rather than actual weight may provide more accurate results. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Effect of volume of distribution'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26868/abstract/1\">",
"      Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1996; 7:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26868/abstract/2\">",
"      Blake P, Burkart JM, Churchill DN, et al. Recommended clinical practices for maximizing peritoneal dialysis clearances. Perit Dial Int 1996; 16:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26868/abstract/3\">",
"      Burkart JM, Schreiber M, Korbet SM, et al. Solute clearance approach to adequacy of peritoneal dialysis. Perit Dial Int 1996; 16:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26868/abstract/4\">",
"      NKF-DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy. V. Adequate dose of peritoneal dialysis. Am J Kidney Dis 2001; 37(Suppl 1):S65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26868/abstract/5\">",
"      K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy. Am J Kidney Dis 2006; 47(Suppl 4):S1.",
"     </a>",
"    </li>",
"    <li>",
"     Chen, HH, Shetty, A, Afthentopoulos, IE, et al. Discrepancy between weekly Kt/V and weekly creatinine clearance in patients on CAPD. In: Advances in Peritoneal Dialysis, vol 11, Khanna, R (Ed), Peritoneal Dialysis Publications, Inc, Toronto 1995. p.83.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26868/abstract/7\">",
"      Vonesh EF, Burkart J, McMurray SD, Williams PF. Peritoneal dialysis kinetic modeling: validation in a multicenter clinical study. Perit Dial Int 1996; 16:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26868/abstract/8\">",
"      Satko SG, Burkart JM, Bleyer AJ, et al. Frequency and causes of discrepancy between Kt/V and creatinine clearance. Perit Dial Int 1999; 19:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26868/abstract/9\">",
"      Vonesh EF, Moran J. Discrepancies between urea KT/V versus normalized creatinine clearance. Perit Dial Int 1997; 17:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26868/abstract/10\">",
"      Tzamaloukas AH, Murata GH, Piraino B, et al. Peritoneal urea and creatinine clearances in continuous peritoneal dialysis patients with different types of peritoneal solute transport. Kidney Int 1998; 53:1405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26868/abstract/11\">",
"      Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980; 33:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26868/abstract/12\">",
"      Dubois, D, Dubois, EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17:863.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1879 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-220.255.2.107-317DDF55DB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_15_26868=[""].join("\n");
var outline_f26_15_26868=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18390890\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SOLUTE CLEARANCE IN PERITONEAL DIALYSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Peritoneal membrane transport",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Effect of volume of distribution",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18390890\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/1879\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/1879|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?43/39/44670\" title=\"figure 1\">",
"      Solute clearance over time PD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/26/6574\" title=\"figure 2\">",
"      PET rapid vs slow transporters",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?37/32/38413\" title=\"figure 3\">",
"      Ccr v KtV by transporter type",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?22/22/22894\" title=\"figure 4\">",
"      Ccr v KtV by gender in PD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/1879|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/22/5484\" title=\"table 1\">",
"      Body weight in PD adequacy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/58/1962?source=related_link\">",
"      Adequacy of peritoneal dialysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/23/35190?source=related_link\">",
"      Calculation of the creatinine clearance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/23/36215?source=related_link\">",
"      Rapid transporters on maintenance peritoneal dialysis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_15_26869="Nalbuphine: Pediatric drug information";
var content_f26_15_26869=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Nalbuphine: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?13/45/14038?source=see_link\">",
"    see \"Nalbuphine: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?42/46/43747?source=see_link\">",
"    see \"Nalbuphine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1054240\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Analgesic, Narcotic",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Opioid Partial Agonist",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1054231\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?13/45/14038?source=see_link\">",
"      see \"Nalbuphine: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children 1-14 years: Premedication: I.M., I.V., SubQ: 0.2 mg/kg; maximum dose: 20 mg/dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children: Analgesia: I.M., I.V., SubQ: 0.1-0.15 mg/kg every 3-6 hours as needed; maximum single-dose: 20 mg/dose; maximum daily dose: 160 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Analgesia: I.M., I.V., SubQ: 10 mg/70 kg every 3-6 hours as needed; maximum single-dose: 20 mg/dose; maximum daily dose: 160 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Surgical anesthesia supplement: I.V.: Induction: 0.3-3 mg/kg administered over 10-15 minutes; maintenance doses of 0.25-0.5 mg/kg may be given as required",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Opioid-induced pruritus: I.V.: 2.5-5 mg; may repeat dose (Cohen, 1992)",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F199274\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as hydrochloride: 10 mg/mL (10 mL); 20 mg/mL (10 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as hydrochloride [preservative free]: 10 mg/mL (1 mL); 20 mg/mL (1 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F199260\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1054243\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Parenteral: I.V.: Administer over 5-10 minutes; larger doses should be administered over 10-15 minutes",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F199329\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     NS, D",
"     <sub>",
"      10",
"     </sub>",
"     W, LR, NS.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Acyclovir, amifostine, aztreonam, bivalirudin, cisatracurium, cladribine, dexmedetomidine, etoposide phosphate, fenoldopam, filgrastim, fludarabine, gemcitabine, granisetron, hetastarch in lactate electrolyte injection (Hextend&reg;), linezolid, melphalan, oxaliplatin, paclitaxel, propofol, remifentanil, teniposide, thiotepa, vinorelbine.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Allopurinol, amphotericin B cholesteryl sulfate complex, cefepime, docetaxel, methotrexate, nafcillin, pemetrexed, piperacillin/tazobactam, sargramostim, sodium bicarbonate.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Compatible:",
"     </b>",
"     Atropine, cimetidine, diphenhydramine, droperidol, glycopyrrolate, hydroxyzine, lidocaine, midazolam, prochlorperazine edisylate, ranitidine, scopolamine, trimethobenzamide.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Diazepam, dimenhydrinate, ketorolac, pentobarbital.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Promethazine.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1054235\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at controlled room temperature at 25&deg;C (77&deg;F); protect from excessive light; store product in carton until used; not physically compatible with nafcillin and ketorolac",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1054242\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Relief of moderate to severe pain; supplement to balanced anesthesia [for preoperative and postoperative analgesia, and obstetrical analgesia (during labor and delivery)]; prevention or treatment of opioid-induced pruritus",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F199331\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Nubain may be confused with Navane&reg;, Nebcin",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F199328\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Central nervous system: Dizziness, headache, sedation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Nausea/vomiting, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Clamminess",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Abdominal pain, agitation, allergic reaction, anaphylaxis, anaphylactoid reaction, anxiety, asthma, bitter taste, blurred vision, bradycardia, cardiac arrest, confusion, crying, delusion, depersonalization, depression, diaphoresis, dreams (abnormal), dyspepsia, dysphoria, dyspnea, euphoria, faintness, fever, floating sensation, flushing, gastrointestinal cramps, hallucinations, hostility, hypertension, hypotension,  injection site reactions (pain, swelling, redness, burning); laryngeal edema, loss of consciousness,  nervousness, numbness, pruritus, pulmonary edema, rash, respiratory depression, respiratory distress, restlessness, seizure, sensation of warmth/burning, somnolence, speech disorder, stridor, tachycardia, tingling, tremor, unreality, urinary urgency, urticaria",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1054247\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to nalbuphine or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1054230\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reduce dose in patients with hepatic impairment; use with caution in patients with CNS depression, impaired respiration, recent MI, or biliary tract surgery; may produce respiratory depression or bradycardia; use with caution in patients with a history of drug dependence, head trauma or increased intracranial pressure, decreased hepatic or renal function, or patients suspected to be opioid dependent",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1054229\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Abrupt discontinuation after prolonged use may result in narcotic withdrawal; administration to patients receiving chronic opiates may precipitate narcotic withdrawal",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Neonatal and fetal adverse reactions have occurred after administration of nalbuphine to pregnant women during labor; these adverse reactions, which may be life-threatening, include: Bradycardia, respiratory depression, apnea, cyanosis, and hypotonia; use with caution in pregnancy; monitor neonates closely with maternal use in labor and delivery.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299737\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F199269\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alvimopan: Analgesics (Opioid) may enhance the adverse/toxic effect of Alvimopan. This is most notable for patients receiving long-term (i.e., more than 7 days) opiates prior to alvimopan initiation.  Management: Alvimopan is contraindicated in patients receiving therapeutic doses of opioids for more than 7 consecutive days immediately prior to alvimopan initiation.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ammonium Chloride: May increase the excretion of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: May enhance the analgesic effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Analgesics (Opioid): Mixed Agonist / Antagonist Opioids may diminish the analgesic effect of Analgesics (Opioid).  Management: Seek alternatives to mixed agonist/antagonist opioids in patients receiving pure opioid agonists, and monitor for symptoms of therapeutic failure/high dose requirements (or withdrawal in opioid-dependent patients) if patients receive these combinations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antipsychotic Agents (Phenothiazines): May enhance the hypotensive effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Desmopressin: Analgesics (Opioid) may enhance the adverse/toxic effect of Desmopressin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mixed Agonist / Antagonist Opioids: May diminish the analgesic effect of Analgesics (Opioid). Management: Seek alternatives to mixed agonist/antagonist opioids in patients receiving pure opioid agonists, and monitor for symptoms of therapeutic failure/high dose requirements (or withdrawal in opioid-dependent patients) if patients receive these combinations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pegvisomant: Analgesics (Opioid) may diminish the therapeutic effect of Pegvisomant.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: Analgesics (Opioid) may enhance the serotonergic effect of Selective Serotonin Reuptake Inhibitors. This may cause serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Succinylcholine: May enhance the bradycardic effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: Analgesics (Opioid) may enhance the orthostatic hypotensive effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F199270\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F199283\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Severe fetal bradycardia has been reported following use in labor/delivery. Fetal bradycardia may occur when administered earlier in pregnancy (not documented). Use only if clearly needed, with monitoring to detect and manage possible adverse fetal effects. Naloxone has been reported to reverse bradycardia. Newborn should be monitored for respiratory depression or bradycardia following nalbuphine use in labor.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1054239\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Relief of pain, respiratory and mental status, blood pressure",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1054228\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Binds to opiate receptors in the CNS, causing inhibition of ascending pain pathways, altering the perception of and response to pain; produces generalized CNS depression; opiate antagonistic effect may result from competitive inhibition at the opiate mu receptor",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1054245\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.M., SubQ: Within 15 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: 2-3 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Maximum effect:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.M.: 30 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: 1-3 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: 3-6 hours",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1054246\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Crosses placenta; distributes into breast milk in small amounts (&lt;1% of dose)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: In the liver; extensive first-pass metabolism",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: &sim;50%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life, terminal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 1-8 years: 0.9 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults 23-32 years: &sim;2 hours; range: 3.5-5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults 65-90 years: 2.3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.M.: 30 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: 1-3 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Metabolites primarily in feces (via bile) and in urine; 4% to 7% eliminated unchanged in the urine",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1054237\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?42/46/43747?source=see_link\">",
"      see \"Nalbuphine: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid alcohol; may cause drowsiness and impair ability to perform activities requiring mental alertness or physical coordination; may impair judgment; may be habit-forming; avoid abrupt discontinuation after prolonged use; will cause withdrawal in patients currently dependent on narcotics; may cause dry mouth",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1054248\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Analgesic potency: 1 mg nalbuphine &sim;1 mg morphine",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Cohen SE, Ratner EF, Kreitzman TR, et al, &ldquo;Nalbuphine is Better Than Naloxone for Treatment of Side Effects After Epidural Morphine,&rdquo;",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 1992, 75(5):747-52.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/15/26869/abstract-text/1416128 /pubmed\" id=\"1416128 \" target=\"_blank\">",
"        1416128",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Jaillon P, Gardin ME, Lecocq B, et al, &ldquo;Pharmacokinetics of Nalbuphine in Infants, Young Healthy Volunteers, and Elderly Patients,&rdquo;",
"      <i>",
"       Clin Pharmacol Ther",
"      </i>",
"      , 1989, 46(2):226-33.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/15/26869/abstract-text/ 2758732 /pubmed\" id=\" 2758732 \" target=\"_blank\">",
"        2758732",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kendrick WD, Woods AM, Daly MY, et al, &ldquo;Naloxone Versus Nalbuphine Infusion for Prophylaxis of Epidural Morphine-Induced Pruritus,&rdquo;",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 1996, 82:641-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/15/26869/abstract-text/8623975/pubmed\" id=\"8623975\" target=\"_blank\">",
"        8623975",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kjellberg F and Tramer MR, \"Pharmacological Control of Opioid-Induced Pruritus: A Quantitative Systematic Review of Randomized Trials,\"",
"      <i>",
"       Eur J Anaesthesiol",
"      </i>",
"      , 2001, 18(6):346-57.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/15/26869/abstract-text/11412287/pubmed\" id=\"11412287\" target=\"_blank\">",
"        11412287",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Nakatsuka N, Minogue SC, Lim J, et al, \"Intravenous Nalbuphine 50 Microg x kg(-1) is Ineffective for Opioid-Induced Pruritus in Pediatrics,\"",
"      <i>",
"       Can J Anaesth",
"      </i>",
"      , 2006, 53(11):1103-10.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/15/26869/abstract-text/17079637/pubmed\" id=\"17079637\" target=\"_blank\">",
"        17079637",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12627 Version 38.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-125.39.66.150-851E2265C2-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_15_26869=[""].join("\n");
var outline_f26_15_26869=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1054240\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1054231\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F199274\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F199260\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1054243\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F199329\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1054235\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1054242\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F199331\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F199328\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1054247\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1054230\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1054229\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299737\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F199269\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F199270\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F199283\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1054239\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1054228\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1054245\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1054246\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1054237\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1054248\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12627\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12627|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?13/45/14038?source=related_link\">",
"      Nalbuphine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?42/46/43747?source=related_link\">",
"      Nalbuphine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_15_26870="Psoriasis on the face";
var content_f26_15_26870=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F68576&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F68576&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Psoriasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythematous, scaly plaques are present on the face.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_15_26870=[""].join("\n");
var outline_f26_15_26870=null;
var title_f26_15_26871="Koilonychia 1";
var content_f26_15_26871=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86418%7EDERM%2F86419&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86418%7EDERM%2F86419&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 520px\">",
"   <div class=\"ttl\">",
"    Koilonychia (spoon nail) associated with iron deficiency",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 500px; height: 374px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Photo courtesy of Moise L Levy, MD. Reproduced with permission from: Chung EK, Boom JA, Datto GA, Matz PS. Visual Diagnosis in Pediatrics. Philadelphia: Lippincott Williams &amp; Wilkins, 2006. Copyright &copy; 2006 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Koilonychia (spoon nail) associated with iron deficiency",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 282px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Stedman's Medical Dictionary. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_15_26871=[""].join("\n");
var outline_f26_15_26871=null;
var title_f26_15_26872="Platelet clumping in EDTA";
var content_f26_15_26872=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F68949&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F68949&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pseudothrombocytopenia due to platelet clumping in EDTA",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 430px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This peripheral blood smear shows platelet clumping (arrows) in an EDTA-anticoagulated blood sample. This patient had an EDTA-dependent platelet agglutinin which caused in vitro platelet clumping, resulting in an artifactually low platelet count (ie, \"pseudothrombocytopenia\"). No platelet clumping was seen, and the platelet count was normal, in a blood sample from this patient anticoagulated with sodium citrate.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Beutler, E, Lichtman, MA, Coller, BS, et al, Hematology, 5th ed, McGraw-Hill, New York, 1995.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal peripheral blood smear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 393px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of a normal peripheral blood smear. Several platelets (black arrows) and a normal lymphocyte (blue arrow) can also be seen. The red cells are of relatively uniform size and shape. The diameter of the normal red cell should approximate that of the nucleus of the small lymphocyte; central pallor (red arrow) should equal one-third of its diameter.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carola von Kapff, SH (ASCP).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_15_26872=[""].join("\n");
var outline_f26_15_26872=null;
var title_f26_15_26873="Urethral diverticulum in women";
var content_f26_15_26873=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Urethral diverticulum in women",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/15/26873/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/15/26873/contributors\">",
"     Lieschen H Quiroz, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/15/26873/contributors\">",
"     Robert E Gutman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/15/26873/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/15/26873/contributors\">",
"     Linda Brubaker, MD, FACS, FACOG",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/15/26873/contributors\">",
"     Deborah Levine, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/15/26873/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/15/26873/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/15/26873/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 7, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A urethral diverticulum is a localized outpouching of the urethral mucosa into the surrounding non-urothelial tissues [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/1\">",
"     1",
"    </a>",
"    ]. This is an uncommon condition that is found mainly in adult women. The possibility of this diagnosis is often overlooked, even in women with presenting symptoms or findings (eg, urinary incontinence, dysuria, dyspareunia, vaginal mass). Delayed or missed diagnosis of this condition can lead to chronic morbidity including urethral calculus formation, chronic or recurrent urinary tract infections (UTIs) or, rarely, malignant transformation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The epidemiology, diagnosis, evaluation, and treatment of urethral diverticula in women are reviewed here. Diagnosis and management of other etiologies of urinary incontinence or dyspareunia are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/14/29929?source=see_link\">",
"     \"Clinical presentation and diagnosis of urinary incontinence\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/1/43032?source=see_link\">",
"     \"Approach to the woman with sexual pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The reported prevalence of urethral diverticula ranges from 1 to 5 percent in adult females, based upon data from studies of autopsy specimens or urethrography series [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. However, the true prevalence may be higher, given the difficulty of accurate and timely diagnosis. Urethral diverticula have rarely been reported in men or in children [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Urethral diverticula typically present between the ages of 20 and 60 years [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/1,4\">",
"     1,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Risk factors for a urethral diverticulum include female gender, pelvic trauma, and periurethral procedures, but there are no data to quantify these risks [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/7-9\">",
"     7-9",
"    </a>",
"    ]. It appears that black women are three-fold more likely than white women to have a urethral diverticulum, based upon data from hospital admissions and surgical procedures related to this diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ANATOMY AND HISTOPATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The female urethra is a tubular structure 2.5 to 4 cm in length and approximately 0.6 cm in diameter that runs from the bladder to the urethral meatus in the anterior aspect of the vulvar vestibule (",
"    <a class=\"graphic graphic_figure graphicRef72614 \" href=\"UTD.htm?24/50/25379\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/10\">",
"     10",
"    </a>",
"    ]. Along its path, it passes from the retropubic space and perforates the perineal membrane.",
"   </p>",
"   <p>",
"    The periurethral glands are located medially and posterolaterally along the distal two-thirds of the urethra and drain into the distal third of the urethra. The periurethral glands secrete mucin that acts as sealant and contributes to urinary continence [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/1\">",
"     1",
"    </a>",
"    ]. Skene glands are periurethral glands found on either side of the urethra and are the female homologues of the prostate in males, since they arise from the urogenital sinus.",
"   </p>",
"   <p>",
"    The proximal third of the urethra is lined by transitional epithelium and the distal two-thirds by squamous epithelium. The type of epithelial cells lining a diverticulum is usually identical to the epithelium of the urethra in the area of the diverticulum. Histologic changes commonly found within urethral diverticula include squamous metaplasia, adenomatous metaplasia, cystitis cystica, and cystitis glandularis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/1,11\">",
"     1,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The morphology of diverticula is heterogeneous. Most urethral diverticula occur in the middle or distal portion of the posterior aspect of the urethra [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/11\">",
"     11",
"    </a>",
"    ]. Diverticula range in size from 0.3 to 5.0 cm in diameter. They may be unilocular or multilocular. More than one diverticulum may be present. The neck that connects the diverticulum to the urethral lumen may be closed, very narrow, or wide.",
"   </p>",
"   <p>",
"    Diverticula are classified as simple or complex. Complex diverticula include multiple diverticula, those involving the urethral sphincter or bladder neck, horseshoe-shaped and saddle diverticula (diverticular sac that partially or circumferentially surrounds the urethra) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urethral diverticula are thought to be acquired rather than congenital in nearly all cases [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/1,5\">",
"     1,5",
"    </a>",
"    ]; they are rarely found in neonates. The pathogenesis is not clearly understood.",
"   </p>",
"   <p>",
"    The most widely proposed theory is that a urethral diverticulum develops as a result of repeated infection of the periurethral glands, leading to obstruction and enlargement of the",
"    <span class=\"nowrap\">",
"     glands/ducts",
"    </span>",
"    and formation of a suburethral abscess [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/1\">",
"     1",
"    </a>",
"    ]. Eventually the abscess ruptures into the urethral lumen, creating a communication between the lumen and the abscess cavity. Evidence of chronic inflammation is supported by histopathology studies [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/13\">",
"     13",
"    </a>",
"    ]. Chronic inflammation results in marked fibrosis within and surrounding the diverticulum, often with accompanying adherence to the neighboring structures.",
"   </p>",
"   <p>",
"    Other possible etiologies include trauma, which may derive from any type of lower genital tract trauma, including vaginal, bladder, or urethral surgery or vaginal delivery. Diverticula have been reported as a rare complication following a midurethral sling procedure or after transurethral collagen injection [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/7-9\">",
"     7-9",
"    </a>",
"    ]. Although trauma associated with vaginal delivery has been postulated as an etiology, the disorder often occurs in nulliparous women. As an example, one series reported that 30 percent of 121 urethral diverticula occurred in nulliparous women [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with a urethral diverticulum may present with postvoid dribbling of urine and an anterior vaginal wall mass, particularly a tender mass. In addition, the presentation may include dysuria or dyspareunia.",
"   </p>",
"   <p>",
"    A high index of suspicion is essential for making the diagnosis. This is because urethral diverticulum is an uncommon condition and many of the presenting symptoms (urinary incontinence, dysuria, dyspareunia) are more frequently associated with other etiologies. In addition, some women may have both a urethral diverticulum and another more common condition; for example, stress urinary incontinence (SUI) is a common condition in women, and the symptoms of this condition may obscure the concurrent presence of postvoid dribbling. As a result, diagnosis is often delayed. In one series of 46 patients with urethral diverticula, the mean time from onset of symptoms to diagnosis was 5.2 years [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H708897\">",
"    <span class=\"h2\">",
"     Symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presenting symptoms of a urethral diverticulum are highly variable. Patients may also be asymptomatic.",
"   </p>",
"   <p>",
"    The classic presentation includes the following triad of symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/11,15\">",
"     11,15",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Postvoid dribbling (4 to 31 percent)",
"     </li>",
"     <li>",
"      Dysuria (9 to 55 percent) &nbsp;",
"     </li>",
"     <li>",
"      Dyspareunia (6 to 24 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other potential presenting complaints include [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/2,11,15\">",
"     2,11,15",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Chronic or recurrent urinary tract infections (UTIs) (9 to 61 percent)",
"     </li>",
"     <li>",
"      Urinary frequency",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      urgency (6 to 38 percent)",
"     </li>",
"     <li>",
"      Hematuria (2 to 13 percent)",
"     </li>",
"     <li>",
"      Bloody urethral discharge (2 percent)",
"     </li>",
"     <li>",
"      Urinary incontinence (29 to 39 percent)",
"     </li>",
"     <li>",
"      Urinary retention (2 to 19 percent)",
"     </li>",
"     <li>",
"      Pelvic or urethral pain (6 to 48 percent)",
"     </li>",
"     <li>",
"      Vaginal mass (6 to 50 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Recurrent UTI may be related to urinary stasis in the diverticulum. Urinary incontinence may be secondary to periurethral support defects, compromise of the urethral sphincter, or drainage of urine from the diverticulum.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Vaginal mass",
"    </span>",
"    &nbsp;&mdash;&nbsp;A palpable vaginal mass is present in up to half of the patients with a urethral diverticulum [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/2\">",
"     2",
"    </a>",
"    ]. Tenderness is often present with palpation of the mass.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2637002\">",
"    <span class=\"h1\">",
"     EVALUATION OF WOMEN WITH A SUSPECTED URETHRAL DIVERTICULUM",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2637119\">",
"    <span class=\"h2\">",
"     Medical history",
"    </span>",
"    &nbsp;&mdash;&nbsp;The medical history should include questions regarding symptoms associated with a urethral diverticulum. (See",
"    <a class=\"local\" href=\"#H708897\">",
"     'Symptoms'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    For women with urinary incontinence or postvoid dribbling, a voiding diary is often helpful to characterize the pattern and amount of incontinence (",
"    <a class=\"graphic graphic_figure graphicRef69130 \" href=\"UTD.htm?4/30/4591\">",
"     figure 2",
"    </a>",
"    ). Bloody urethral discharge must be differentiated from vaginal or anal bleeding. One approach to confirming the source of bleeding is to ask the patient to dab each area with toilet paper after an episode and note if blood is present.",
"   </p>",
"   <p>",
"    Women who report dyspareunia should be asked whether the pain is localized to the anterior vaginal wall.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2637111\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urethral diverticula are usually located at the middle or distal portion on the posterior aspect of the urethra. An anterior vaginal wall mass is found on physical examination in many, but not all, patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/15\">",
"     15",
"    </a>",
"    ]. The finding of suburethral mass on examination does not confirm the diagnosis of a urethral diverticulum. Further evaluation is required to exclude other conditions or associated findings. (See",
"    <a class=\"local\" href=\"#H707559\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    To best visualize the anterior vaginal wall during the pelvic examination, the anterior vaginal wall is first visualized by using a half speculum to retract the posterior vaginal wall. The anterior vaginal wall is inspected while the patient rests and then does a Valsalva maneuver.",
"   </p>",
"   <p>",
"    The anterior wall and the course of the urethra are then palpated to assess for findings that suggest the presence of a diverticulum (a suburethral mass, fullness, or tenderness). An attempt should also be made to express urine or purulent or bloody discharge from the suburethral mass. Palpating the suspicious area with and then without a bladder catheter in the urethral lumen may help to distinguish a true urethral mass from conditions that may give the appearance of a mass, such as redundant vaginal epithelium associated with anterior vaginal wall prolapse.",
"   </p>",
"   <p>",
"    Most urethral diverticula are soft. A firm mass may represent malignancy or a calculus, and warrants further evaluation. (See",
"    <a class=\"local\" href=\"#H21970996\">",
"     'Evaluation to exclude associated conditions'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8714148\">",
"    <span class=\"h2\">",
"     Urine tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with symptoms of dysuria, urinary urgency or frequency, or hematuria, a urinalysis should be performed. If leukocytes are present, a urine culture should be sent to exclude infection. Women with hematuria should be evaluated for other conditions, including urinary tract malignancy, as appropriate. (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/15/13561?source=see_link\">",
"     \"Acute uncomplicated cystitis and pyelonephritis in women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/59/34746?source=see_link\">",
"     \"Etiology and evaluation of hematuria in adults\"",
"    </a>",
"    )",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H707664\">",
"    <span class=\"h2\">",
"     Imaging studies and endoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are few data to guide the choice of diagnostic study for urethral diverticula. We suggest magnetic resonance imaging (MRI) as the first line imaging study for patients with a suburethral mass and symptoms consistent with a urethral diverticulum. MRI appears to have the best diagnostic performance and can also help to exclude clinically important features of a diverticulum (ie, solid mass suggestive of malignancy, calculi) or other periurethral conditions. (See",
"    <a class=\"local\" href=\"#H21970996\">",
"     'Evaluation to exclude associated conditions'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H707559\">",
"     'Differential diagnosis'",
"    </a>",
"    below.) &nbsp;",
"   </p>",
"   <p>",
"    It is reasonable to use ultrasound as the first line study if MRI is not feasible due to expense or lack of available expertise in the interpretation of an MRI regarding this condition. However, ultrasound findings may be nonspecific and require further evaluation with MRI. &nbsp;",
"   </p>",
"   <p>",
"    Urethroscopy is performed only as an adjunct to MRI or ultrasound to provide information regarding the anatomic relationship of the diverticular ostium to the urethra.",
"   </p>",
"   <p>",
"    Traditionally, contrast-enhanced radiography (eg, voiding cystourethrography, retrograde double-balloon positive pressure urethrography) were used to evaluate women for urethral diverticulum. However, these procedures are invasive and technically difficult and the contrast-dependent studies are only able to visualize diverticula that are patent enough to allow filling with contrast material [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/16\">",
"     16",
"    </a>",
"    ]. Thus, these studies have largely been replaced by MRI or ultrasound.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Magnetic resonance imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;MRI appears to be effective for the diagnosis of urethral diverticulum, but this is based upon limited data from small observational studies [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/17-23\">",
"     17-23",
"    </a>",
"    ]. No studies have compared MRI with other imaging modalities for evaluation of this condition.",
"   </p>",
"   <p>",
"    Case series with 40 to 60 women with a suspected diverticulum who were evaluated with MRI have reported that the sensitivity for the diagnosis of urethral diverticulum was 86 to 100 percent and the specificity was 95 to 100 percent; the reference standard was either surgical findings or a second imaging study [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. The sensitivity of MRI in evaluating urethral masses may also depend upon the expertise of the radiologist reading the study.",
"   </p>",
"   <p>",
"    Advantages of MRI compared with ultrasound or urethroscopy are that it allows better visualization of diverticula that are small or noncommunicating and provides multiplanar resolution lending superior tissue resolution and allowing for differentiation between normal anatomical variants, soft tissue masses, and urethral pathology (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef82937 graphicRef82938 graphicRef82939 \" href=\"UTD.htm?29/49/30490\">",
"     image 1A-C",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In terms of technique, most reports have found that use of an endoluminal coil (endourethral, endovaginal, or endorectal) is a useful technique for evaluating the urethra and periurethral region [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/18,19,23\">",
"     18,19,23",
"    </a>",
"    ]. Detection of multiple diverticula is optimally achieved using MRI with slices from just above the bladder neck to the distal urethra.",
"   </p>",
"   <p>",
"    MRI is potentially better able than ultrasound to detect findings such as a solid mass within the diverticulum (which may signify malignancy) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/18\">",
"     18",
"    </a>",
"    ]. In addition, malignancy should be suspected if the wall of the diverticulum is focally thickened or irregular. Alternatively, infection and inflammation can lead to a more diffusely thick-walled and hyperemic appearance. Use of contrast will show contrast enhancement in the lesion. (See",
"    <a class=\"local\" href=\"#H21971004\">",
"     'Malignant or benign neoplasms'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    However, MRI may miss some diagnoses of malignancy. As an example, in one study with 41 women, 2 patients were found to have malignancy within the wall of a urethral diverticulum at time of surgery, but no findings suggestive of this were detected with preoperative MRI [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    On MRI, the appearance of calculi is dependent upon the imaging sequence utilized. On T2-weighted imaging, a calculus appears with low signal intensity. If the calculus is surrounded by fluid within a diverticulum, the fluid will be bright on T2 weighted imaging, and the stone will be seen as a filling defect. (See",
"    <a class=\"local\" href=\"#H21971020\">",
"     'Calculi'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnostic performance of ultrasound for evaluation of urethral diverticulum has been evaluated only in small case series. A study comparing ultrasound (transvaginal, transperineal, or endourethral) to voiding cystourethrography found that both studies were able to diagnose 13 of 15 urethral diverticula, but ultrasound was also able to diagnose periurethral cysts and leiomyomas not detected by voiding cystourethrography [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/25\">",
"     25",
"    </a>",
"    ]. In another study, 10 cases of urethral diverticulum diagnosed with transvaginal ultrasound were confirmed with surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When ultrasound is used to assess for a urethral diverticulum, transvaginal ultrasonography is the preferred technique. Transabdominal, transrectal, or transperineal approaches provide images of lower quality than transvaginal; transurethral ultrasound has been reported, but is rarely used due to expense and patient discomfort [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In terms of technique for transvaginal ultrasound, the probe is partially inserted into the vagina, and imaging is directed to the expected location and course of the urethra. A high frequency probe (&gt;7 MHz) is used for real-time visualization of the diverticular wall and its contents, and to measure the overall size and circumference of the urethral mass (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef82806 \" href=\"UTD.htm?20/0/20482\">",
"     image 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/25,27\">",
"     25,27",
"    </a>",
"    ]. The patient should have a partially full bladder during the examination for anatomical orientation. Color Doppler may be used if there is a finding of a solid mass suggestive of malignancy [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    On ultrasound, a finding of a soft tissue mass within a diverticulum with flow on Doppler is suggestive of malignancy. An irregular or thickened diverticular wall may be noted. As discussed above, wall thickening may also result from infection or inflammation. Color Doppler will show flow to the region of suspicion. (See",
"    <a class=\"local\" href=\"#H21971004\">",
"     'Malignant or benign neoplasms'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Calculi are seen on ultrasound as strongly echogenic masses with shadowing within the diverticulum. (See",
"    <a class=\"local\" href=\"#H21971020\">",
"     'Calculi'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2637536\">",
"    <span class=\"h3\">",
"     Urethroscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urethroscopy may be used as an adjunct to MRI or ultrasound to provide information regarding the anatomic relationship of the diverticular ostium to the urethra. This information can be helpful during surgical treatment. This procedure permits visual examination of the urethral epithelium and urethrovesical junction and may be useful in diverticula with large ostia (",
"    <a class=\"graphic graphic_picture graphicRef54925 \" href=\"UTD.htm?30/7/30846\">",
"     picture 1",
"    </a>",
"    ). The limitations of this procedure are that it cannot visualize beyond the ostium of the diverticulum, does not provide information on the size or complexity of the diverticulum, causes patient discomfort, and is expensive if performed in an operating room setting. If urethroscopy is not performed as part of the preoperative evaluation, we recommend starting surgical treatment with urethroscopy. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H707652\">",
"    <span class=\"h3\">",
"     Tests no longer recommended",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h4\">",
"     Voiding cystourethrography",
"    </span>",
"    &nbsp;&mdash;&nbsp;This test is no longer recommended for routine evaluation of urethral diverticulum since it is uncomfortable for the patient, has limited diagnostic performance, and involves exposure to radiation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. The sensitivity is low, approximately 65 percent, which may be attributable to inadequate filling of the diverticulum through a stenotic ostium. In addition, this study does not provide images of periurethral lesions that are necessary to exclude other conditions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h4\">",
"     Retrograde positive pressure urethrography",
"    </span>",
"    &nbsp;&mdash;&nbsp;This test is no longer recommended for routine evaluation of urethral diverticulum since it is uncomfortable for the patient, has limited diagnostic performance, and involves exposure to radiation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/29\">",
"     29",
"    </a>",
"    ]. Similar to voiding cystourethrography, retrograde double-balloon positive pressure urethrography is not effective for detecting stenotic diverticula and also does not provide images of periurethral lesions to exclude other conditions. The test is performed by occluding each end of the urethra by a double balloon catheter. Contrast medium is then infused under pressure into an opening in the urethral portion of the catheter in order to distend any urethral communication.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H707641\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of urethral diverticulum is made by urethral and periurethral imaging, preferably magnetic resonance imaging (MRI), in women with characteristic symptoms",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a periurethral mass. For women who undergo surgical treatment, the diagnosis is confirmed at time of surgery. (See",
"    <a class=\"local\" href=\"#H707664\">",
"     'Imaging studies and endoscopy'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    More than a single diverticulum may be present, so after identifying a single diverticulum, it is prudent to search for additional diverticula.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H707559\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of a urethral diverticulum depends upon the presenting symptoms and findings. For women with a periurethral mass, other diagnostic possibilities include other urinary or genital tract lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/30\">",
"     30",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Vaginal or urethral benign or malignant neoplasm (eg, vaginal leiomyoma, vaginal wall inclusion cyst, Gartner&rsquo;s duct cyst, vaginal cancer, urethral cancer)",
"     </li>",
"     <li>",
"      Anterior vaginal wall prolapse",
"     </li>",
"     <li>",
"      Periurethral fibrosis",
"     </li>",
"     <li>",
"      Ectopic ureterocele",
"     </li>",
"     <li>",
"      Skene gland abscess",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The evaluation required to exclude these conditions depends upon the patient&rsquo;s other clinical features. The most common condition in the differential diagnosis is anterior vaginal wall prolapse, which typically involves the entire anterior vaginal wall on examination, while a urethral diverticulum is generally palpable as a discrete mass. If other conditions are suspected, imaging should be performed. Depending upon the imaging findings, biopsy or surgical exploration may be required to differentiate some conditions from a urethral diverticulum. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/33/40473?source=see_link\">",
"     \"An overview of the epidemiology, risk factors, clinical manifestations, and management of pelvic organ prolapse in women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/11/12473?source=see_link\">",
"     \"Diagnosis and management of congenital anomalies of the vagina\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/8/41093?source=see_link\">",
"     \"Ureterocele\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Women with postvoid dribbling of urine should be evaluated for other etiologies of urinary incontinence. Urinary incontinence in the absence of elevated intraabdominal pressure (suggestive of stress incontinence) or a feeling of urinary urgency (suggestive of urge incontinence) raises suspicion of ectopic ureters, urinary tract fistula, or a urethral diverticulum. Incomplete bladder emptying (overflow incontinence) or obstructive voiding symptoms should also be excluded. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/14/29929?source=see_link\">",
"     \"Clinical presentation and diagnosis of urinary incontinence\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Urinary tract infection (UTI) should be excluded in women with dysuria and urinary frequency or urgency. If infection is not found, other etiologies of these symptoms should be investigated, including interstitial",
"    <span class=\"nowrap\">",
"     cystitis/bladder",
"    </span>",
"    pain syndrome or overactive bladder syndrome. Persistent, sterile pyuria may also raise suspicion for a diverticulum. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/15/13561?source=see_link\">",
"     \"Acute uncomplicated cystitis and pyelonephritis in women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/8/8330?source=see_link\">",
"     \"Pathogenesis, clinical features, and diagnosis of interstitial cystitis/bladder pain syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some women with a urethral diverticulum have gross or microscopic hematuria. Women with hematuria should be evaluated for other conditions, including urinary tract malignancy and renal abnormalities, as appropriate. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/59/34746?source=see_link\">",
"     \"Etiology and evaluation of hematuria in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Women who present with dyspareunia should be evaluated for other etiologies of sexual pain. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/1/43032?source=see_link\">",
"     \"Approach to the woman with sexual pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21970996\">",
"    <span class=\"h1\">",
"     EVALUATION TO EXCLUDE ASSOCIATED CONDITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the diagnosis of a urethral diverticulum is made, the patient should be evaluated for associated conditions that impact treatment choices, including: malignancy, benign neoplasms, or a diverticular calculus. In many patients, these conditions are identified during the diagnostic evaluation process.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21971004\">",
"    <span class=\"h2\">",
"     Malignant or benign neoplasms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malignancy has been reported in 6 to 9 percent of patients with a urethral diverticulum [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/1,11\">",
"     1,11",
"    </a>",
"    ]. These are usually adenocarcinomas, but transitional and squamous cell tumors have been reported. In addition, precancerous lesions or findings associated with malignancy have been found (ie, dysplasia, villous adenoma).",
"   </p>",
"   <p>",
"    There are no specific symptoms associated with malignancy. Malignancy should be suspected if a solid mass in a diverticulum is found on examination",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    imaging. The imaging features are discussed above. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Magnetic resonance imaging'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H11\">",
"     'Ultrasound'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    If malignancy is suspected on an imaging study, surgical excision should be performed. Alternatively, in some cases, malignancy is found incidentally following surgical removal of the diverticulum. Women with urethral malignancy should undergo staging and treatment, as appropriate. (See",
"    <a class=\"local\" href=\"#H326272\">",
"     'Patients with bothersome symptoms or suspected malignancy or calculi'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/35/34357?source=see_link\">",
"     \"Urethral cancer in women\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    Benign neoplasms have also been found in urethral diverticula [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/31\">",
"     31",
"    </a>",
"    ]. One study of 90 patients found 10 nephrogenic adenomas [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/11\">",
"     11",
"    </a>",
"    ]. Women with benign diverticular neoplasm are typically diagnosed following surgical treatment, since they present with imaging findings of a solid mass, similar to malignant lesions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21971020\">",
"    <span class=\"h2\">",
"     Calculi",
"    </span>",
"    &nbsp;&mdash;&nbsp;Calcium oxalate or calcium phosphate stones have been reported in 2 to 10 percent of urethral diverticula [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/15\">",
"     15",
"    </a>",
"    ]. Stone formation is likely due to urinary stasis within the diverticulum, salt deposition, and periglandular mucus.",
"   </p>",
"   <p>",
"    Women with a diverticular calculus typically present with the same symptoms as other women with a diverticulum. Calculi of larger sizes can sometimes be palpated as a solid mass on examination, and are nearly always visualized on imaging studies. The imaging features are discussed above. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Magnetic resonance imaging'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H11\">",
"     'Ultrasound'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Diverticulectomy with calculi removal prevents recurrence. (See",
"    <a class=\"local\" href=\"#H326272\">",
"     'Patients with bothersome symptoms or suspected malignancy or calculi'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with a urethral diverticulum who have no bothersome symptoms may be managed with conservative measures. If bothersome symptoms are present or there is a suspicion of malignancy or a diverticular calculus, surgical treatment is required. Transvaginal diverticulectomy is the surgical procedure of choice.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H326047\">",
"    <span class=\"h2\">",
"     Patients without bothersome symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conservative management is a reasonable option for women without bothersome symptoms and without signs suggestive of malignancy or a urethral calculus. Conservative measures are intended to minimize postvoid dribbling and prevent urinary tract infection (UTI), however, there are no data regarding their efficacy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H708034\">",
"    <span class=\"h3\">",
"     Conservative management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conservative management includes: digital decompression by applying pressure on the suburethral mass after voiding or periodic needle aspiration [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Antibiotic prophylaxis may be used in women with recurrent UTIs, but surgical treatment should also be offered to these patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/24/5514?source=see_link&amp;anchor=H17#H17\">",
"     \"Recurrent urinary tract infection in women\", section on 'Antimicrobial prophylaxis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These measures may allow resolution of localized symptoms, but the anatomic abnormality remains. The long-term prognosis of patients treated conservatively is not known. There are no guidelines regarding surveillance for patients undergoing conservative management. In our practice, we perform periodic clinical assessments every 6 to 12 months, including an examination. If bothersome symptoms develop, patients should be evaluated with imaging and treated surgically.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H326272\">",
"    <span class=\"h2\">",
"     Patients with bothersome symptoms or suspected malignancy or calculi",
"    </span>",
"    &nbsp;&mdash;&nbsp;For women with bothersome symptoms or a diverticular calculus, we suggest surgical treatment rather than conservative management. Surgery is indicated if a diverticular malignancy is suspected.",
"   </p>",
"   <p>",
"    No studies have compared surgical procedures for urethral diverticula. Transvaginal diverticulectomy is the procedure of choice since it is a definitive procedure. For patients with a diverticulum that is distal to the urethral sphincter, a marsupialization procedure is a reasonable option. The choice of a particular procedure is also dependent upon the individual surgeon&rsquo;s expertise. Procedures for treatment of urethral diverticula should be performed only by surgeons with experience with vaginal and periurethral surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H326309\">",
"    <span class=\"h3\">",
"     Transvaginal diverticulectomy",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H326452\">",
"    <span class=\"h4\">",
"     Preoperative preparation",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients should undergo periurethral imaging with magnetic resonance imaging (MRI) or ultrasound prior to surgery to define the number, size, and location of diverticula. (See",
"    <a class=\"local\" href=\"#H707664\">",
"     'Imaging studies and endoscopy'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Preoperative counseling should include a discussion of possible complications, including the potential for urinary incontinence, as well as details about postoperative care (see",
"    <a class=\"local\" href=\"#H326642\">",
"     'Concomitant incontinence procedures'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H326793\">",
"     'Outcome and complications'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    UTI or periurethral abscess should be treated with antibiotics treatment preoperatively. For acute abscesses, incision and drainage may be required. Failure to completely treat infection may increase the risk of surgical complications.",
"   </p>",
"   <p>",
"    Antibiotics for prevention of surgical site infection are typically administered for this procedure. The infectious risk is similar to other procedures that involve a vaginal wall or lower urinary tract incision. Antibiotics for prevention of endocarditis are not required. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/8/7306?source=see_link&amp;anchor=H25711799#H25711799\">",
"     \"Pelvic organ prolapse in women: Surgical repair of anterior vaginal wall prolapse\", section on 'Antibiotic prophylaxis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=see_link&amp;anchor=H14#H14\">",
"     \"Antimicrobial prophylaxis for bacterial endocarditis\", section on 'Genitourinary and gastrointestinal tracts'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These procedures are typically brief and thromboprophylaxis is not required if the patient has no risk factors for venous thromboembolism. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/52/41802?source=see_link&amp;anchor=H5#H5\">",
"     \"Prevention of venous thromboembolic disease in surgical patients\", section on 'Surgical risk groups'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H326493\">",
"    <span class=\"h4\">",
"     Procedure",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goal of this procedure is complete excision of the diverticular sac and closure of the communication with the urethral lumen (",
"    <a class=\"graphic graphic_picture graphicRef58369 \" href=\"UTD.htm?41/48/42752\">",
"     picture 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The procedure is as follows (",
"    <a class=\"graphic graphic_figure graphicRef82606 \" href=\"UTD.htm?41/42/42661\">",
"     figure 3",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The patient is placed in the dorsal lithotomy position and sterile preparation is performed. Urethroscopy is often undertaken prior to surgical incision in an attempt to visualize the exact location of the ostium of the diverticulum to help guide surgical dissection. (See",
"      <a class=\"local\" href=\"#H2637536\">",
"       'Urethroscopy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A size 14 or 16 French bladder catheter is inserted into the urethra and an incision is made on the anterior vaginal wall under the urethra and urethrovesical junction. Several different types of vaginal incisions have been employed, including vertical midline, U-shaped, inverted U-shaped, semilunar, and transverse. Choice of incision should be made based on the best access to the diverticulum. The inverted U-shaped incision avoids overlapping suture lines. &nbsp;",
"     </li>",
"     <li>",
"      The vaginal epithelium is dissected off the periurethral pubocervical fibromuscularis with Metzenbaum scissors. This dissection should be superficial.",
"     </li>",
"     <li>",
"      An incision is made in the pubocervical fibromuscularis, typically a transverse incision, which is then mobilized to expose the diverticulum. This can be difficult, as the fibromuscularis is often attenuated or adherent to the wall of the diverticulum.",
"     </li>",
"     <li>",
"      An attempt is made to isolate and mobilize the diverticulum intact; however, often the diverticulum ruptures during this process. If the diverticulum is intact, it is excised after proper identification of its communication with the bladder neck. If the diverticulum ruptures, placing a finger into the lumen of the diverticulum sac facilitates dissection of the residual sac toward the urethral communication.",
"     </li>",
"     <li>",
"      The diverticulum is excised flush to its communication with the urethral lumen. Similar to the vaginal repair of vesicovaginal or urethrovaginal fistulae, the entire communication at the junction with the urethra need not be excised. Such excision of the entire communication may result in a larger urethral defect that may predispose to further complications without increasing the overall cure rate.",
"     </li>",
"     <li>",
"      The urethral wall is reapproximated with 3-0 or 4-0 polyglactin suture over a Foley catheter in a continuous or interrupted fashion. Most urethral closures are performed longitudinally, but this may increase the risk of urethral stenosis in cases of large ostia.",
"     </li>",
"     <li>",
"      The periurethral fibromuscularis is closed transversely or in an overlapping fashion depending on the degree of attenuation using 2-0 or 3-0 polyglactin suture. The goal is to avoid an overlapping suture line with the urethral closure.",
"      <br/>",
"      <br/>",
"      In cases where there is poor quality devascularized tissue or inadequate pubocervical fibromuscularis to perform a layered closure, a bulbocavernosus fat pad interposition (Martius flap), may be used to increase vascularity in hopes of decreasing the risk of urethrovaginal fistula formation.",
"     </li>",
"     <li>",
"      The anterior vaginal wall incision is closed with 2-0 or 3-0 polyglactin suture. A vaginal pack with estrogen cream may be applied for additional hemostasis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H326642\">",
"    <span class=\"h4\">",
"     Concomitant incontinence procedures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diverticulectomy may involve disruption of the \"continent zone\" of the urethra. This portion is located in the middle portion of the urethra and is surrounded by the striated urogenital sphincter.",
"   </p>",
"   <p>",
"    Patients without preexisting stress urinary incontinence (SUI) should be counseled about the possible development of incontinence if the continence zone is disturbed during the procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/33\">",
"     33",
"    </a>",
"    ]. A literature review reported that postoperative SUI develops in 1.7 to 12.5 percent of women following surgical treatment of a diverticulum [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some surgeons advocate performing a concomitant SUI procedure at the time of diverticular excision [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. Other surgeons disagree with this approach, since many patients will not develop urinary incontinence [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/32\">",
"     32",
"    </a>",
"    ]. In addition, many patients with a diverticulum are young and anti-incontinence procedures are not typically performed in women who have not completed childbearing. There are insufficient data regarding this issue to make a recommendation regarding concomitant continence surgery at the time of surgical treatment of a urethral diverticulum. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/10/43177?source=see_link&amp;anchor=H5#H5\">",
"     \"Stress urinary incontinence in women: Choosing a primary surgical procedure\", section on 'Women finished with childbearing'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The choice of anti-incontinence may differ for patients with a urethral diverticulum. Synthetic mesh midurethral slings are generally the procedure of choice for SUI. However, for women with a urethral diverticulum, an important concern is that placement of synthetic material near the line of the fresh incision may result in mesh erosion. For this reason, the use of a pubovaginal sling with autologous fascia is a better choice, although there are few data regarding this issue [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/36\">",
"     36",
"    </a>",
"    ]. An alternative to a concomitant incontinence procedure would be to perform a staged procedure, with a midurethral sling if SUI develops. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/10/43177?source=see_link&amp;anchor=H17#H17\">",
"     \"Stress urinary incontinence in women: Choosing a primary surgical procedure\", section on 'Midurethral slings versus other procedures'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Future childbearing plans must be considered when determining whether or not to perform a concomitant stress incontinence surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/10/43177?source=see_link&amp;anchor=H5#H5\">",
"     \"Stress urinary incontinence in women: Choosing a primary surgical procedure\", section on 'Women finished with childbearing'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H326505\">",
"    <span class=\"h4\">",
"     Postoperative care",
"    </span>",
"    &nbsp;&mdash;&nbsp;In our practice, we leave in a 14 to 16 French urethral catheter (with or without a suprapubic catheter) for 7 to 14 days after diverticulectomy. If there is extensive dissection and it is felt there may be voiding dysfunction even after 7 to 14 days, a suprapubic catheter may be preferable. The duration of catheterization depends upon the size of the urethral defect.",
"   </p>",
"   <p>",
"    We perform a voiding cystourethrogram (VCUG) 14 days after surgery to evaluate the integrity of the repair. If a small amount of extravasation is seen, we continue bladder drainage and repeat the VCUG the following week. Once no extravasation is seen, we begin voiding trials, making sure that the patient is able to empty her bladder adequately (eg, postvoid residual &lt;100 mL). However, there are no data to support the routine use of VCUG postoperatively. An alternative approach is to perform a retrograde bladder instillation of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/10/15522?source=see_link\">",
"     indigo carmine",
"    </a>",
"    into the urethra and bladder and examine the vaginal incision lines for evidence of a fistula.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H326793\">",
"    <span class=\"h4\">",
"     Outcome and complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Observational studies have reported that transvaginal diverticulectomy is associated with cure of diverticulum-related symptoms in approximately 70 to 86 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. The reported rate of recurrent diverticula ranges from 1 to 25 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Complications are common, however, likely due to the extensive dissection required to surgically excise the diverticulum. The most common postoperative complications are urethrovaginal fistula (1 to 8 percent), SUI (1 to 16 percent), urethral strictures (0 to 5 percent), and recurrent UTIs (7 to 31 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/34\">",
"     34",
"    </a>",
"    ]. Profuse hemorrhage may occur intraoperatively, especially during bladder neck diverticulectomy. Although less common, excision of a large proximal diverticulum may result in ureteric injury.",
"   </p>",
"   <p>",
"    Risk factors for developing postoperative complications include delayed diagnosis of the diverticulum (&gt;12 months after the onset of symptoms), large size (&gt;4 cm), lateral or horseshoe shape diverticulum, or repeat diverticulectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients who undergo repeat surgery for a urethral diverticulum are at increased risk for postoperative complications such as recurrent diverticula, urethral stricture, and urethrovaginal fistulas [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/40\">",
"     40",
"    </a>",
"    ]. In cases of recurrent urethral diverticulum repair, additional reconstruction with dorsal on-lay buccal mucosal graft or Martius graft interposition may improve outcomes and prevent urethral stricture for large urethral defects. The addition of an autologous fascial sling has also been suggested to improve success by providing posterior urethral support in patients with and without stress incontinence symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H326426\">",
"    <span class=\"h3\">",
"     Other surgical procedures",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h4\">",
"     Urethroscopic excision",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urethroscopic excision of the ostium using a cold urethrotome proximally and distally to open the roof of the diverticulum, thereby promoting drainage of contents into the urethral lumen [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/41\">",
"     41",
"    </a>",
"    ]. This endoscopic is not considered a definitive surgical procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h4\">",
"     Marsupialization",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 1976, Spence and Duckett described a procedure for the management of distal urethral diverticula [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/42\">",
"     42",
"    </a>",
"    ]. The surgical approach involved making an incision along the floor of the distal urethra from the external urethral meatus to the orifice of the diverticulum, followed by trimming vaginal mucosa and saucerizing the sac into the vagina. The end-product of the surgery was the appearance of a \"generous meatotomy.\"",
"   </p>",
"   <p>",
"    This technique involves marsupialization of the distal urethral diverticulum resulting in decreased urethral length and a more patulous urethral meatus. Proper patient selection of only distal urethral diverticula is critical so as to avoid further proximal extension of the urethral incision that will compromise the urethral sphincter and overall continence mechanism. Other potential complications include UTI and dyspareunia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H708126\">",
"    <span class=\"h2\">",
"     Pregnant women",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urethral diverticula diagnosed during pregnancy should be managed conservatively during the antenatal period to relieve symptoms and because a large diverticulum may obstruct fetal descent during labor. Excision should not be performed during pregnancy. One study including four cases of urethral diverticula managed conservatively during pregnancy reported that three women underwent urethral decompression by aspiration for symptom relief, and one patient was treated with antibiotic therapy only [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26873/abstract/43\">",
"     43",
"    </a>",
"    ]. Postpartum, three of four women underwent urethral diverticulectomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A urethral diverticulum is a localized outpouching of the urethral mucosa into the surrounding non-urothelial tissues. Most urethral diverticula occur in the middle portion or distal urethra. More than a single diverticulum may be present. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'Anatomy and histopathology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The reported prevalence of urethral diverticula ranges from 1 to 5 percent of women. However, the true prevalence may be higher, given the difficulty of accurate and timely diagnosis. Delayed or missed diagnosis of this condition can lead to chronic morbidities including calculus formation, chronic infections, or malignant transformation. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Urethral diverticulum should be suspected in women with postvoid dribbling of urine and a mass, particularly a tender mass, along the anterior vaginal wall. This condition should also be excluded in women who present with dysuria or dyspareunia. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest magnetic resonance imaging (MRI) rather than other imaging studies or urethroscopy as the first line imaging study for patients with a suburethral mass and symptoms consistent with a urethral diverticulum. MRI appears to have the best diagnostic performance and can also help to exclude associated conditions (ie, solid mass suggestive of malignancy, calculi) or other conditions in the differential diagnosis. Ultrasound is a reasonable alternative if MRI is not feasible due to expense or lack of available expertise in MRI diagnosis of this condition. (See",
"      <a class=\"local\" href=\"#H707664\">",
"       'Imaging studies and endoscopy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of urethral diverticulum is made by urethral and periurethral imaging in women with characteristic symptoms",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      a suburethral mass. For women who undergo surgical treatment, the diagnosis is confirmed at time of surgery. (See",
"      <a class=\"local\" href=\"#H707641\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis of a periurethral mass includes vaginal wall inclusion cyst, Skene gland abscess, Gartner's duct cyst, ectopic ureterocele, periurethral fibrosis, urethrocele, vaginal leiomyoma, and urethral or vaginal neoplasm. (See",
"      <a class=\"local\" href=\"#H707559\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Conservative management of a urethral diverticulum is a reasonable option for women who have no bothersome symptoms and in whom there is no suspicion of malignancy or a diverticular calculus. (See",
"      <a class=\"local\" href=\"#H326047\">",
"       'Patients without bothersome symptoms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For women with bothersome symptoms or a diverticular calculus, we suggest surgical treatment rather than conservative management (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Surgery is indicated if a diverticular malignancy is suspected.",
"     </li>",
"     <li>",
"      We suggest transvaginal diverticulectomy rather than other surgical procedures (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). For patients with a diverticulum that is distal to the urethral sphincter, a marsupialization procedure is a reasonable option. (See",
"      <a class=\"local\" href=\"#H326272\">",
"       'Patients with bothersome symptoms or suspected malignancy or calculi'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Surgical treatment of a diverticulum may disrupt the continence zone of the urethra. The decision of whether to perform a concomitant continence procedure at the time of surgical treatment should be individualized. (See",
"      <a class=\"local\" href=\"#H326642\">",
"       'Concomitant incontinence procedures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Surgical cure rates after diverticular excision are approximately 70 to 86 percent. The most common postoperative complications are recurrent diverticulum, urethrovaginal fistula, stress incontinence, urethral strictures, and recurrent urinary tract infections (UTIs). (See",
"      <a class=\"local\" href=\"#H326793\">",
"       'Outcome and complications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/1\">",
"      Foley CL, Greenwell TJ, Gardiner RA. Urethral diverticula in females. BJU Int 2011; 108 Suppl 2:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/2\">",
"      Romanzi LJ, Groutz A, Blaivas JG. Urethral diverticulum in women: diverse presentations resulting in diagnostic delay and mismanagement. J Urol 2000; 164:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/3\">",
"      M&aring;rtensson O, Duchek M. Translabial ultrasonography with pulsed colour-Doppler in the diagnosis of female urethral diverticula. Scand J Urol Nephrol 1994; 28:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/4\">",
"      Burrows LJ, Howden NL, Meyn L, Weber AM. Surgical procedures for urethral diverticula in women in the United States, 1979-1997. Int Urogynecol J Pelvic Floor Dysfunct 2005; 16:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/5\">",
"      Kadian YS, Rattan KN, Singh M, Kajal P. Congenital anterior urethral diverticulum in children: a case report and review. ISRN Surg 2011; 2011:120307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/6\">",
"      Alphs HH, Meeks JJ, Casey JT, Gonzalez CM. Surgical reconstruction of the male urethral diverticulum. Urology 2010; 76:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/7\">",
"      Athanasopoulos A, McGuire EJ. Urethral diverticulum: a new complication associated with tension-free vaginal tape. Urol Int 2008; 81:480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/8\">",
"      Clemens JQ, Bushman W. Urethral diverticulum following transurethral collagen injection. J Urol 2001; 166:626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/9\">",
"      Morton HC, Hilton P. Urethral injury associated with minimally invasive mid-urethral sling procedures for the treatment of stress urinary incontinence: a case series and systematic literature search. BJOG 2009; 116:1120.",
"     </a>",
"    </li>",
"    <li>",
"     Stepp KJ, Walters MD. Anatomy of the lower urinary tract, rectum, and pelvic floor. In: Urogynecology and Reconstructive Surgery, 3rd, Walters, MD, Karram, MM.  (Eds), Mosby Elsevier, Philadelphia 2007. p.17.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/11\">",
"      Thomas AA, Rackley RR, Lee U, et al. Urethral diverticula in 90 female patients: a study with emphasis on neoplastic alterations. J Urol 2008; 180:2463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/12\">",
"      Rovner ES, Wein AJ. Diagnosis and reconstruction of the dorsal or circumferential urethral diverticulum. J Urol 2003; 170:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/13\">",
"      Tsivian M, Tsivian A, Shreiber L, et al. Female urethral diverticulum: a pathological insight. Int Urogynecol J Pelvic Floor Dysfunct 2009; 20:957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/14\">",
"      DAVIS HJ, TELINDE RW. Urethral diverticula: an assay of 121 cases. J Urol 1958; 80:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/15\">",
"      Aspera AM, Rackley RR, Vasavada SP. Contemporary evaluation and management of the female urethral diverticulum. Urol Clin North Am 2002; 29:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/16\">",
"      Chou CP, Levenson RB, Elsayes KM, et al. Imaging of female urethral diverticulum: an update. Radiographics 2008; 28:1917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/17\">",
"      Kim B, Hricak H, Tanagho EA. Diagnosis of urethral diverticula in women: value of MR imaging. AJR Am J Roentgenol 1993; 161:809.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/18\">",
"      Daneshgari F, Zimmern PE, Jacomides L. Magnetic resonance imaging detection of symptomatic noncommunicating intraurethral wall diverticula in women. J Urol 1999; 161:1259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/19\">",
"      Lorenzo AJ, Zimmern P, Lemack GE, Nurenberg P. Endorectal coil magnetic resonance imaging for diagnosis of urethral and periurethral pathologic findings in women. Urology 2003; 61:1129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/20\">",
"      Neitlich JD, Foster HE Jr, Glickman MG, Smith RC. Detection of urethral diverticula in women: comparison of a high resolution fast spin echo technique with double balloon urethrography. J Urol 1998; 159:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/21\">",
"      Blander DS, Rovner ES, Schnall MD, et al. Endoluminal magnetic resonance imaging in the evaluation of urethral diverticula in women. Urology 2001; 57:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/22\">",
"      Foster RT, Amundsen CL, Webster GD. The utility of magnetic resonance imaging for diagnosis and surgical planning before transvaginal periurethral diverticulectomy in women. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/23\">",
"      Dwarkasing RS, Dinkelaar W, Hop WC, et al. MRI evaluation of urethral diverticula and differential diagnosis in symptomatic women. AJR Am J Roentgenol 2011; 197:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/24\">",
"      Chung DE, Purohit RS, Girshman J, Blaivas JG. Urethral diverticula in women: discrepancies between magnetic resonance imaging and surgical findings. J Urol 2010; 183:2265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/25\">",
"      Siegel CL, Middleton WD, Teefey SA, et al. Sonography of the female urethra. AJR Am J Roentgenol 1998; 170:1269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/26\">",
"      Gerrard ER Jr, Lloyd LK, Kubricht WS, Kolettis PN. Transvaginal ultrasound for the diagnosis of urethral diverticulum. J Urol 2003; 169:1395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/27\">",
"      Lee JW, Fynes MM. Female urethral diverticula. Best Pract Res Clin Obstet Gynaecol 2005; 19:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/28\">",
"      Golomb J, Leibovitch I, Mor Y, et al. Comparison of voiding cystourethrography and double-balloon urethrography in the diagnosis of complex female urethral diverticula. Eur Radiol 2003; 13:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/29\">",
"      Jacoby K, Rowbotham RK. Double balloon positive pressure urethrography is a more sensitive test than voiding cystourethrography for diagnosing urethral diverticulum in women. J Urol 1999; 162:2066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/30\">",
"      Dmochowski RR, Ganabathi K, Zimmern PE, Leach GE. Benign female periurethral masses. J Urol 1994; 152:1943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/31\">",
"      Greco A, Giamm&ograve; A, Tizzani A. [Nephrogenic adenoma arising from an urethral diverticulum in a female. Report of a case and review of the literature]. Minerva Urol Nefrol 1999; 51:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/32\">",
"      Fortunato P, Schettini M, Gallucci M. Diagnosis and therapy of the female urethral diverticula. Int Urogynecol J Pelvic Floor Dysfunct 2001; 12:51.",
"     </a>",
"    </li>",
"    <li>",
"     Delancey, JO. Anatomy of the Female Bladder and Urethra. In: Ostergard's Urogynecology and Pelvic Floor Dysfunction, 5th ed, Bent, AE (Ed), Lippincott Williams &amp; Wilkins, Philadelphia PA 2003. p. 3.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/34\">",
"      Ganabathi K, Leach GE, Zimmern PE, Dmochowski R. Experience with the management of urethral diverticulum in 63 women. J Urol 1994; 152:1445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/35\">",
"      Swierzewski SJ 3rd, McGuire EJ. Pubovaginal sling for treatment of female stress urinary incontinence complicated by urethral diverticulum. J Urol 1993; 149:1012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/36\">",
"      Migliari R, Pistolesi D, D'Urso L, Muto G. Recurrent pseudodiverticula of female urethra: five-year experience. Urology 2009; 73:1218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/37\">",
"      Bennett SJ. Urethral diverticula. Eur J Obstet Gynecol Reprod Biol 2000; 89:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/38\">",
"      Scarpero HM, Dmochowski RR, Leu PB. Female urethral diverticula. Urol Clin North Am 2011; 38:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/39\">",
"      Porpiglia F, Destefanis P, Fiori C, Fontana D. Preoperative risk factors for surgery female urethral diverticula. Our experience. Urol Int 2002; 69:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/40\">",
"      Ljungqvist L, Peeker R, Fall M. Female urethral diverticulum: 26-year followup of a large series. J Urol 2007; 177:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/41\">",
"      Lapides J. Transurethral treatment of urethral diverticula in women. J Urol 1979; 121:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/42\">",
"      Spence HM, Duckett JW Jr. Diverticulum of the female urethra: clinical aspects and presentation of a simple operative technique for cure. J Urol 1970; 104:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26873/abstract/43\">",
"      Moran PA, Carey MP, Dwyer PL. Urethral diverticula in pregnancy. Aust N Z J Obstet Gynaecol 1998; 38:102.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8075 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-61.234.146.186-2A6F391156-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_15_26873=[""].join("\n");
var outline_f26_15_26873=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ANATOMY AND HISTOPATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H708897\">",
"      Symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Vaginal mass",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2637002\">",
"      EVALUATION OF WOMEN WITH A SUSPECTED URETHRAL DIVERTICULUM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2637119\">",
"      Medical history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2637111\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8714148\">",
"      Urine tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H707664\">",
"      Imaging studies and endoscopy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Ultrasound",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2637536\">",
"      - Urethroscopy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H707652\">",
"      - Tests no longer recommended",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Voiding cystourethrography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Retrograde positive pressure urethrography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H707641\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H707559\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21970996\">",
"      EVALUATION TO EXCLUDE ASSOCIATED CONDITIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21971004\">",
"      Malignant or benign neoplasms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21971020\">",
"      Calculi",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H326047\">",
"      Patients without bothersome symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H708034\">",
"      - Conservative management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H326272\">",
"      Patients with bothersome symptoms or suspected malignancy or calculi",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H326309\">",
"      - Transvaginal diverticulectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H326452\">",
"      Preoperative preparation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H326493\">",
"      Procedure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H326642\">",
"      Concomitant incontinence procedures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H326505\">",
"      Postoperative care",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H326793\">",
"      Outcome and complications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H326426\">",
"      - Other surgical procedures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Urethroscopic excision",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Marsupialization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H708126\">",
"      Pregnant women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/8075\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/8075|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?39/60/40900\" title=\"diagnostic image 1A\">",
"      MRI urethral diverticulum1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?25/14/25829\" title=\"diagnostic image 1B\">",
"      MRI urethral diverticulum2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?25/53/26451\" title=\"diagnostic image 1C\">",
"      MRI urethral diverticulum3",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?20/0/20482\" title=\"diagnostic image 2\">",
"      Ultrasound urethral diverticulum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/8075|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/50/25379\" title=\"figure 1\">",
"      Vulvar anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?4/30/4591\" title=\"figure 2\">",
"      Voiding diary",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?41/42/42661\" title=\"figure 3\">",
"      Resec urethral diverticulum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/8075|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/7/30846\" title=\"picture 1\">",
"      Pos pressure urethroscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/48/42752\" title=\"picture 2\">",
"      Excision ureth diverticulum",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/15/13561?source=related_link\">",
"      Acute uncomplicated cystitis and pyelonephritis in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/33/40473?source=related_link\">",
"      An overview of the epidemiology, risk factors, clinical manifestations, and management of pelvic organ prolapse in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=related_link\">",
"      Antimicrobial prophylaxis for bacterial endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/1/43032?source=related_link\">",
"      Approach to the woman with sexual pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/14/29929?source=related_link\">",
"      Clinical presentation and diagnosis of urinary incontinence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/11/12473?source=related_link\">",
"      Diagnosis and management of congenital anomalies of the vagina",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/59/34746?source=related_link\">",
"      Etiology and evaluation of hematuria in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/8/8330?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of interstitial cystitis/bladder pain syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/8/7306?source=related_link\">",
"      Pelvic organ prolapse in women: Surgical repair of anterior vaginal wall prolapse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/52/41802?source=related_link\">",
"      Prevention of venous thromboembolic disease in surgical patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/24/5514?source=related_link\">",
"      Recurrent urinary tract infection in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/10/43177?source=related_link\">",
"      Stress urinary incontinence in women: Choosing a primary surgical procedure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/8/41093?source=related_link\">",
"      Ureterocele",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/35/34357?source=related_link\">",
"      Urethral cancer in women",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_15_26874="Clinical features and diagnosis of Down syndrome";
var content_f26_15_26874=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical features and diagnosis of Down syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/15/26874/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/15/26874/contributors\">",
"     Kathryn K Ostermaier, MD, FAAP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/15/26874/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/15/26874/contributors\">",
"     Jan E Drutz, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/15/26874/contributors\">",
"     Helen V Firth, DM, FRCP, DCH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/15/26874/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/15/26874/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/15/26874/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 4, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Down syndrome (DS) is the most common chromosome abnormality among liveborn infants. It is the most frequent form of intellectual disability (mental retardation) caused by a microscopically demonstrable chromosomal aberration. DS is characterized by a variety of dysmorphic features, congenital malformations, and other health problems and medical conditions. Not all of them are present in each affected individual. The impact of Down syndrome for each person is individual, with some individuals being profoundly impacted, while others are healthy and able to live independently as adults. In general, individuals with Down syndrome are now reaching fuller potentials secondary to better educational programs, medical advancements, community resources, and the support of family and friends.",
"   </p>",
"   <p>",
"    The clinical features and diagnosis of Down syndrome will be presented here. The epidemiology, genetics, and management are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/27/22969?source=see_link&amp;anchor=H4#H4\">",
"     \"Overview of prenatal screening and diagnosis of Down syndrome\", section on 'Candidates for prenatal screening and diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/0/23562?source=see_link&amp;anchor=H9#H9\">",
"     \"Congenital cytogenetic abnormalities\", section on 'Trisomy 21 (Down syndrome)'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/58/13224?source=see_link\">",
"     \"Management of Down syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DYSMORPHIC FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Each characteristic dysmorphic feature of Down syndrome (DS) is present in 47 to 82 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. These features predominantly affect the head and neck and the extremities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Head and neck",
"    </span>",
"    &nbsp;&mdash;&nbsp;Characteristic dysmorphic features of DS affecting the head and neck include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Upslanting palpebral fissures",
"     </li>",
"     <li>",
"      Epicanthic folds (",
"      <a class=\"graphic graphic_picture graphicRef64030 \" href=\"UTD.htm?11/15/11505\">",
"       picture 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Flat facial",
"      <span class=\"nowrap\">",
"       profile/flat",
"      </span>",
"      nasal bridge",
"     </li>",
"     <li>",
"      Folded or dysplastic ears",
"     </li>",
"     <li>",
"      Low-set small ears",
"     </li>",
"     <li>",
"      Brachycephalic",
"     </li>",
"     <li>",
"      Brushfield spots",
"     </li>",
"     <li>",
"      Open mouth",
"     </li>",
"     <li>",
"      Protruding tongue (",
"      <a class=\"graphic graphic_picture graphicRef64030 \" href=\"UTD.htm?11/15/11505\">",
"       picture 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Furrowed tongue",
"     </li>",
"     <li>",
"      Short neck",
"     </li>",
"     <li>",
"      Excessive skin at nape of the neck",
"     </li>",
"     <li>",
"      Narrow palate",
"     </li>",
"     <li>",
"      Abnormal teeth",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Extremities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Characteristic dysmorphic features of DS affecting the extremities include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Short broad hands",
"     </li>",
"     <li>",
"      Incurved fifth finger with hypoplastic mid phalanx",
"     </li>",
"     <li>",
"      Transverse palmar crease (",
"      <a class=\"graphic graphic_picture graphicRef79414 \" href=\"UTD.htm?26/22/26991\">",
"       picture 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Space between the first and second toes (sandal gap)",
"     </li>",
"     <li>",
"      Hyperflexibility of joints",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12589040\">",
"    <span class=\"h2\">",
"     Neonatal features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ten of the characteristic dysmorphic features are common in newborns with DS and are usually recognized soon after birth. In a series of 48 affected newborns, all had four or more features and 89 percent had six or more [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/1,3\">",
"     1,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Flat facial profile",
"     </li>",
"     <li>",
"      Slanted palpebral fissures",
"     </li>",
"     <li>",
"      Anomalous ears",
"     </li>",
"     <li>",
"      Hypotonia (",
"      <a class=\"graphic graphic_picture graphicRef68246 \" href=\"UTD.htm?41/34/42543\">",
"       picture 3",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Poor Moro reflex",
"     </li>",
"     <li>",
"      Dysplasia of midphalanx of fifth finger",
"     </li>",
"     <li>",
"      Transverse palmar (Simian) crease (",
"      <a class=\"graphic graphic_picture graphicRef79414 \" href=\"UTD.htm?26/22/26991\">",
"       picture 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Excessive skin at nape of the neck",
"     </li>",
"     <li>",
"      Hyperflexibility of joints",
"     </li>",
"     <li>",
"      Dysplasia of pelvis",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     INTELLECTUAL DISABILITY (MENTAL RETARDATION)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Almost all individuals with DS have cognitive impairment, although the range is wide. Most are mildly to moderately intellectually disabled, with IQ in the 50 to 70 or 35 to 50 range, respectively, although some are severely impaired with IQ 20 to 35 [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/10/26793?source=see_link\">",
"     \"Intellectual disability (mental retardation) in children: Definition; causes; and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Developmental impairment becomes apparent in the first year of life. In general, the average age of sitting (11 months), creeping (17 months), and walking (26 months) is twice the typical age [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/5\">",
"     5",
"    </a>",
"    ]. The sequence of language development is the same, although the rate is slower, with the average age for the first word at 18 months [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/6\">",
"     6",
"    </a>",
"    ]. The child with DS continues to learn new skills. However, IQ declines through the first 10 years of age, reaching a plateau in adolescence that continues into adulthood [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/2,7,8\">",
"     2,7,8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/29/19928?source=see_link\">",
"     \"Developmental and behavioral screening tests in primary care\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The profile of cognitive impairment in DS appears to differ from other forms of intellectual disability. The cognitive deficits are primarily in morphosyntax, verbal short-term memory, and explicit long-term memory [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/9\">",
"     9",
"    </a>",
"    ]. The most common profile, in which language comprehension is equal to mental age and language production is more delayed, occurs in two-thirds of affected children [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/10\">",
"     10",
"    </a>",
"    ] In one-third, language comprehension, mental age, and language production are equal. Impairment in expressive language was noted in another study of children with DS, who had fewer different and total words and decreased mean length of utterance compared with controls matched for nonverbal mental age [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/11\">",
"     11",
"    </a>",
"    ]. Vocabulary skills accelerated more rapidly than syntax (average sentence length and structure) and surpassed mental age in adolescence. Similar findings of increasing differences in comprehension with age were noted in another report, in which children with DS developed relatively stronger skills in vocabulary compared with syntax [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/12\">",
"     12",
"    </a>",
"    ]. Other selective deficits have been described, such as greater difficulty understanding sequences or grammatical rules [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/2,13\">",
"     2,13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31550131\">",
"    <span class=\"h2\">",
"     Dementia/Alzheimer disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adults with DS usually develop neuropathologic and functional changes typical of Alzheimer disease by the fifth decade of life [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/8,14,15\">",
"     8,14,15",
"    </a>",
"    ]. In one report, dementia was present in 49 of 96 (51 percent) of DS individuals over the age of 35 years [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/14\">",
"     14",
"    </a>",
"    ]. The average age of onset was 54 years and seizures developed in 84 percent of patients. In another report, over 75 percent over 65 years of age were affected [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/25/28057?source=see_link\">",
"     \"Evaluation of cognitive impairment and dementia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2688065\">",
"    <span class=\"h2\">",
"     Behavioral and psychiatric disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Behavioral and psychiatric disorders are more common in DS than typical children, but less common than in those with other causes of mental retardation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/8\">",
"     8",
"    </a>",
"    ]. In one report, psychiatric disorders affected 17.6 percent of individuals with DS less than 20 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/16\">",
"     16",
"    </a>",
"    ]. Disruptive behavioral disorders, such as attention deficit hyperactivity disorder,",
"    <span class=\"nowrap\">",
"     conduct/oppositional",
"    </span>",
"    disorder, or aggressive behavior, were most common. In the same study, psychiatric disorders, most often consisting of major depressive illness or aggressive behavior, affected 25.6 percent of DS adults. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/18/26922?source=see_link&amp;anchor=H830607547#H830607547\">",
"     \"Attention deficit hyperactivity disorder in children and adolescents: Clinical features and evaluation\", section on 'Clinical features'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/63/32761?source=see_link\">",
"     \"Adult attention deficit hyperactivity disorder\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/13/11481?source=see_link\">",
"     \"Clinical manifestations and diagnosis of depression\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/10/5289?source=see_link\">",
"     \"Depression in adolescents: Epidemiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Autism is a common comorbidity of DS, affecting as many as 7 percent of DS children [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/17\">",
"     17",
"    </a>",
"    ]. The diagnosis is often delayed compared with children without DS [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/41/664?source=see_link&amp;anchor=H3#H3\">",
"     \"Clinical features of autism spectrum disorders\", section on 'Autistic disorder'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     HEART DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately one-half of individuals with DS have congenital heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/19-21\">",
"     19-21",
"    </a>",
"    ]. In the largest population-based study, cardiovascular abnormalities were identified in 342 (42 percent) of 821 infants born with DS from 1985 to 2006 in the North East region of England [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/21\">",
"     21",
"    </a>",
"    ]. Twenty-three percent had more than one anomaly. The secondary lesion was most commonly an atrial septal defect or patent ductus arteriosus. The following primary lesions were identified:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Complete atrioventricular septal defect (CAVSD) &ndash; 37 percent",
"     </li>",
"     <li>",
"      Ventricular septal defect (VSD) &ndash; 31 percent",
"     </li>",
"     <li>",
"      Atrial septal defect (ASD) &ndash; 15 percent",
"     </li>",
"     <li>",
"      Partial atrioventricular septal defect (PAVSD) &ndash; 6 percent",
"     </li>",
"     <li>",
"      Tetralogy of Fallot (TOF) &ndash; 5 percent",
"     </li>",
"     <li>",
"      Patent ductus arteriosus (PDA) &ndash; 4 percent",
"     </li>",
"     <li>",
"      Miscellaneous &ndash; 2 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The clinical features of these defects are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26201?source=see_link\">",
"     \"Classification and clinical features of isolated atrial septal defects in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/19/8506?source=see_link\">",
"     \"Pathophysiology and clinical features of isolated ventricular septal defects in infants and children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/52/35656?source=see_link\">",
"     \"Clinical manifestations and diagnosis of patent ductus arteriosus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/27/13752?source=see_link\">",
"     \"Pathophysiology, clinical features, and diagnosis of tetralogy of Fallot\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some asymptomatic adolescents and adults without structural heart disease develop valve abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. In a series of 35 patients with DS, mitral valve prolapse occurred in 46 percent and aortic regurgitation in six percent at an average age of 20 years [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/22\">",
"     22",
"    </a>",
"    ]. In another report of 30 adults, mitral valve regurgitation occurred in 17 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     GASTROINTESTINAL ABNORMALITIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with trisomy 21 are at increased risk for gastrointestinal tract anomalies, which occur in approximately 5 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/24\">",
"     24",
"    </a>",
"    ]. Duodenal atresia or stenosis, sometimes associated with annular pancreas, is the most characteristic lesion, occurring in 2.5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/2\">",
"     2",
"    </a>",
"    ]. Imperforate anus and esophageal atresia with tracheoesophageal fistula are seen less often. Conversely, DS affects 28 percent of patients with duodenal atresia or stenosis and 20 percent with annular pancreas. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/55/31608?source=see_link\">",
"     \"Intestinal atresia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/55/18293?source=see_link\">",
"     \"Annular pancreas\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/27/29114?source=see_link&amp;anchor=H16#H16\">",
"     \"Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula\", section on 'Tracheoesophageal fistula and esophageal atresia'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/62/34793?source=see_link\">",
"     \"Prenatal diagnosis of gastrointestinal atresia and obstruction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hirschsprung disease is more common in DS than in the general population, although the risk is less than 1 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/4\">",
"     4",
"    </a>",
"    ]. Among children with Hirschsprung disease, approximately 2 percent have trisomy 21, (with a range of 2 to 15 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/25-29\">",
"     25-29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41848?source=see_link\">",
"     \"Congenital aganglionic megacolon (Hirschsprung disease)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A strong association appears to exist between DS and celiac disease. The prevalence of biopsy-proven celiac disease has been reported to be between 5 and 16 percent, representing a 5- to 16-fold increase compared with the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/30-34\">",
"     30-34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/3/37946?source=see_link\">",
"     \"Clinical manifestations and diagnosis of celiac disease in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     GROWTH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Birth weight, length, and head circumference are less in DS compared with typical infants. Newborns with DS weigh approximately 0.18 to 0.37 kg less than their siblings [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/35\">",
"     35",
"    </a>",
"    ]. Mean length at birth is approximately 0.5 standard deviations less than control newborns [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/36\">",
"     36",
"    </a>",
"    ]. In a study of 105 children with Down syndrome, length, weight, and head circumference were below those of normal healthy children at birth; remained lower until puberty, with the growth spurt being earlier (age 11 in boys and 9.5 in girls); and were blunted compared with controls [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Short stature",
"    </span>",
"    &nbsp;&mdash;&nbsp;Growth rate is reduced in DS compared with typical children, especially in infancy and adolescence. Growth is most reduced in children with severe congenital heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/36,38\">",
"     36,38",
"    </a>",
"    ]. In adults with DS, the average height in males and females is 61.7 and 57 inches (157 and 144 cm), respectively, and the average weight is 157 and 140 lb (71 and 64 kg) in males and females [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/39\">",
"     39",
"    </a>",
"    ]. Growth charts for children with DS have been published in populations in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/38,40\">",
"     38,40",
"    </a>",
"    ], Italy [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/41\">",
"     41",
"    </a>",
"    ], the Netherlands [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/42\">",
"     42",
"    </a>",
"    ], and Sweden [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The cause of DS-associated growth retardation remains unknown; low circulating levels of IGF-1 and diminished provoked and spontaneous secretion of GH have been reported in some patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. Serum GH levels are not low in children with DS [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/46,47\">",
"     46,47",
"    </a>",
"    ], but suboptimal endogenous GH production as a result of hypothalamic dysfunction has been demonstrated [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/48\">",
"     48",
"    </a>",
"    ]. Selective deficiency of IGF-1, but not IGF-II, has been seen in Down syndrome patients who are older than two years [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. IGF-1 receptors are present in brain cells from fetuses with trisomy 21 [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Obesity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of obesity (defined as a body mass index &gt;27.8",
"    <span class=\"nowrap\">",
"     kg/m2",
"    </span>",
"    in adult males and &gt;27.3",
"    <span class=\"nowrap\">",
"     kg/m2",
"    </span>",
"    in adult females) is greater in DS than in the general population (45 versus 33 percent, 56 versus 36 percent, for males and females, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/39\">",
"     39",
"    </a>",
"    ]. This is thought to result from the reduced resting metabolic rate in children and adults with DS [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]. In general, weight is less than expected for length in infants with DS, and then increases disproportionally so that the majority of children are obese by age three to four years [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     EYE PROBLEMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ophthalmologic disorders that require monitoring and intervention affect the majority of children with DS. Disorders that are the most common include [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/8,53-57\">",
"     8,53-57",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Refractive errors (myopia, hyperopia, astigmatism) &mdash; 35 to 76 percent",
"     </li>",
"     <li>",
"      Strabismus &mdash; 25 to 57 percent",
"     </li>",
"     <li>",
"      Nystagmus &mdash; 18 to 22 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Cataracts occur in 5 percent of newborns. Starting in the second decade of life, many individuals develop corneal opacities. Children occasionally develop glaucoma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/31/41463?source=see_link\">",
"     \"Overview of glaucoma in infants and children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/14/22761?source=see_link&amp;anchor=H11#H11\">",
"     \"Cataract in children\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The frequency of ocular disorders increases with age. In one report, eye abnormalities occurred in 38 percent of infants 2 to 12 months of age and 80 percent of children age 5 to 12 years [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/53\">",
"     53",
"    </a>",
"    ]. These abnormalities may be more prevalent in adults. In one report, of 30 institutionalized adults with Down syndrome, only one had nearly normal ocular status [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/58\">",
"     58",
"    </a>",
"    ]. Nine had keratoconus, an abnormal shape or thinning of the cornea that impairs visual acuity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     HEARING LOSS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hearing impairment affects 38 to 78 percent of individuals with DS [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/8,59,60\">",
"     8,59,60",
"    </a>",
"    ]. Otitis media is a frequent problem, affecting 50 to 70 percent of DS children [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/4\">",
"     4",
"    </a>",
"    ]. Monitoring for this condition is important to preserve hearing.",
"   </p>",
"   <p>",
"    The characteristics of hearing loss were illustrated by a study of 47 children with DS, 2 months to 3.5 years of age, evaluated by auditory brainstem response testing [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/60\">",
"     60",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The loss was unilateral or bilateral in 28 and 38 percent, respectively; 34 percent of patients had normal hearing",
"     </li>",
"     <li>",
"      The loss was conductive in 19 ears, sensorineural in 16, and mixed in 14",
"     </li>",
"     <li>",
"      The extent of loss was mild, moderate, and severe to profound in 33, 13, and 3 ears, respectively",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Another series of 332 children with DS born in Utah found that [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/61\">",
"     61",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Forty-six percent had hearing loss, 32 percent of whom were identified on newborn screening and the rest in later infancy.",
"     </li>",
"     <li>",
"      Most newborns and infants had conductive hearing loss due to serous otitis media and required placement of tympanostomy tubes, although a few children were identified with sensorineural or mixed hearing loss, primarily identified by newborn screening.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2688495\">",
"    <span class=\"h1\">",
"     ENDOCRINE DISORDERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endocrine abnormalities in DS include thyroid dysfunction and diabetes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2688520\">",
"    <span class=\"h2\">",
"     Thyroid disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thyroid disorders are common in DS. The prevalence varies, depending in part upon the population studied and the age of testing. The prevalence of hypothyroidism ranged from 3 to 54 percent in reports of adults with DS [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/62\">",
"     62",
"    </a>",
"    ]. Hyperthyroidism is also relatively common, occurring in 2.5 percent of institutionalized adults [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thyroid disease is also frequently seen in children with DS, as indicated in the following reports:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a longitudinal study of 85 DS patients up to 25 years of age, 35 percent had hypothyroidism. One-half developed the disorder before age eight years [",
"      <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/62\">",
"       62",
"      </a>",
"      ]. Two percent had hyperthyroidism.",
"     </li>",
"     <li>",
"      In 320 children with DS aged 5 days to 10 years, 28 percent had abnormal thyroid function tests [",
"      <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/64\">",
"       64",
"      </a>",
"      ]. Of these, diagnoses included primary congenital hypothyroidism in six, acquired hypothyroidism in one, transient hyperthyrotropinemia in two, compensated hypothyroidism (T4 concentration normal or close to the lower limit of normal and increased thyroid-stimulating hormone level) in 16, and mild compensated hypothyroidism (mildly elevated thyroid stimulating hormone [TSH] concentration) in 65. None had hyperthyroidism.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, there is a shift in thyroid hormone levels in patients with DS who have no overt symptoms of thyroid disease, suggesting that normal values may be different in this group. In a large cohort from a neonatal screening program, T4 concentrations in newborns with DS had a normal distribution, but were shifted to lower concentrations than the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/65\">",
"     65",
"    </a>",
"    ]. Mean TSH concentration was significantly increased (9.76 versus 3.96",
"    <span class=\"nowrap\">",
"     mIU/L)",
"    </span>",
"    and T4-binding globulin was normal compared with controls. The distribution plots for TSH and free T4 were shifted to higher values in another study of patients with DS (median age 10, range 6 months to 64 years) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2688527\">",
"    <span class=\"h2\">",
"     Diabetes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of type I diabetes appears to be increased in DS [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/34,67-69\">",
"     34,67-69",
"    </a>",
"    ]. Data from a Dutch study in children up to 14 years of age suggest the risk of type I diabetes is three times greater in DS than in the general population (50 versus 12.4 per 100,000 per year) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/68,69\">",
"     68,69",
"    </a>",
"    ]. In another study, the estimated prevalence of type I diabetes in DS children up to nine years of age was eight times greater than the age-matched control population (335 versus 40 per 100,000) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     HEMATOLOGIC DISORDERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hematologic abnormalities affecting red cells, white cells, and platelets are common in DS. The risk of leukemia in DS is 1 to 1.5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/70,71\">",
"     70,71",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Approximately 65 percent of newborns with trisomy 21 have polycythemia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/72\">",
"     72",
"    </a>",
"    ]. In one report, plasma erythropoietin concentration measured in umbilical cord blood was higher in infants with DS compared with controls, suggesting that chronic fetal hypoxemia may explain the high incidence of polycythemia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/73\">",
"     73",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/6/36968?source=see_link\">",
"     \"Neonatal polycythemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Children with DS often have macrocytosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/72,74\">",
"     72,74",
"    </a>",
"    ]. In one study, mean corpuscular volume (MCV) was greater in DS children age two to six years compared with controls (86.9 versus 80.6 fL), and MCV &gt;95th percentile for age was more likely to occur (66 versus 11 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/74\">",
"     74",
"    </a>",
"    ]. Hematocrits were higher in the DS patients (39.1 versus 36.9 percent), although all were normal for age. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/16/21767?source=see_link\">",
"     \"Macrocytosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    White blood cell counts are decreased in DS [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/72,74\">",
"     72,74",
"    </a>",
"    ]. In the study cited above, white blood cell counts &lt;5th percentile for age occurred more often in DS than controls (33 versus 6 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/74\">",
"     74",
"    </a>",
"    ]. The macrocytosis and leukopenia were not explained by folate deficiency because serum and red blood cell folate concentrations were similar between the patients and controls. Thrombocytosis is common in infancy and thrombocytopenia is rare [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/72\">",
"     72",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Transient leukemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transient leukemia, also known as transient myeloproliferative disease (TMD) or transient abnormal myelopoiesis (TAM), is a form of leukemia that almost exclusively affects newborns with DS [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/71,75-77\">",
"     71,75-77",
"    </a>",
"    ]. The combined incidence of cases detected antenatally and postnatally is approximately 20 percent of newborns with DS [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/78\">",
"     78",
"    </a>",
"    ]. The majority of newborns are asymptomatic, with spontaneous resolution of the disorder by two to three months (median 54 days), although some develop severe disease [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/8,78-80\">",
"     8,78-80",
"    </a>",
"    ]. Most of the antenatal cases die before birth with fetal hydrops.",
"   </p>",
"   <p>",
"    Transient leukemia is characterized by the presence of primitive cells (ie, blasts) in the peripheral blood [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/78\">",
"     78",
"    </a>",
"    ]. A mutation in",
"    <em>",
"     GATA1",
"    </em>",
"    , a hematopoietic transcription factor required for normal differentiation of megakaryocytes, is found in blast cells in most patients with transient leukemia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/71,78,81-86\">",
"     71,78,81-86",
"    </a>",
"    ]. The number of blasts varies from few to more than",
"    <span class=\"nowrap\">",
"     200,000/microL.",
"    </span>",
"    Hemoglobin and neutrophil counts are typically normal. Platelet counts are usually normal, although thrombocytopenia or thrombocytosis can occur. Giant platelets and fragments of megakaryocytes may be seen. In the majority of cases, the number of blasts gradually decreases, with blasts and platelet abnormalities spontaneously disappearing before three months of age. In DS infants with transient leukemia, in contrast with acute megakaryoblastic leukemia, the percentage of blasts is lower in bone marrow than in peripheral blood and the bone marrow cytogenetics reveal no clonal abnormalities other than trisomy 21 [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/87\">",
"     87",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most affected patients are asymptomatic, except for vesiculopustular skin eruptions, which are common and resolve as the hematologic disorder regresses [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/88,89\">",
"     88,89",
"    </a>",
"    ]. The lesions contain cells similar to the circulating blasts.",
"   </p>",
"   <p>",
"    However, life-threatening complications can occur [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/90,91\">",
"     90,91",
"    </a>",
"    ]. In a prospective study of 48 children with transient leukemia conducted by the Pediatric Oncology Group, seven developed hepatic fibrosis and two had cardiopulmonary failure [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/90\">",
"     90",
"    </a>",
"    ]. Hepatic fibrosis presents as obstructive jaundice that is progressive and results in death in approximately one-half of the cases [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/90,92\">",
"     90,92",
"    </a>",
"    ]. The mechanism of fibrosis may be related to increased expression of platelet-derived growth factor and transforming growth factor beta 1 in the blast cells [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/93\">",
"     93",
"    </a>",
"    ]. Cardiopulmonary disease typically presents as generalized edema, with pulmonary edema, pericardial effusions, and ascites [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/90,94\">",
"     90,94",
"    </a>",
"    ]. The mechanism is unknown, although myocardial infiltration by blasts may play a role [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In retrospective studies, clinical features associated with early death include preterm delivery, white blood cell count &ge;100,000",
"    <span class=\"nowrap\">",
"     cells/microL,",
"    </span>",
"    direct bilirubin &ge;4.84",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (83",
"    <span class=\"nowrap\">",
"     micromol/L),",
"    </span>",
"    ascites, and bleeding diathesis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/77,91\">",
"     77,91",
"    </a>",
"    ]. In a prospective series of 135 children with DS and TMD, the presence of hepatomegaly and life-threatening symptoms were significantly associated with greater mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/95\">",
"     95",
"    </a>",
"    ]. Overall survival was 92 percent if neither finding was present (n = 51), 77 percent with hepatomegaly alone (n = 55), and 51 percent with both hepatomegaly and life-threatening symptoms (n = 29).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Acute megakaryoblastic leukemia (AMKL)",
"    </span>",
"    &nbsp;&mdash;&nbsp;In prospective and retrospective studies, up to 26 percent of infants with transient leukemia later developed the FAB M7 subtype of acute myeloid leukemia (AML-M7), also known as acute megakaryoblastic leukemia (AMKL) or myeloid leukemia of DS (ML-DS) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/76,78,96\">",
"     76,78,96",
"    </a>",
"    ]. AMKL occurs in approximately 1 in 50 to 200 children with DS. The incidence is approximately 500 times greater in children with than without DS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/50/39720?source=see_link\">",
"     \"Classification of acute myeloid leukemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    AMKL develops during the first four years of life. It is most commonly seen by two years of age and is invariably associated with mutations in",
"    <em>",
"     GATA1",
"    </em>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/71,78,81-86\">",
"     71,78,81-86",
"    </a>",
"    ]. In contrast, myeloid leukemias in people with DS aged four years or older are usually negative for",
"    <em>",
"     GATA1",
"    </em>",
"    mutations, and their prognosis does not differ from AML in patients without DS. Many affected patients (20 to 69 percent) present with myelodysplastic syndrome, consisting of progressive thrombocytopenia followed by anemia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/70\">",
"     70",
"    </a>",
"    ]. Some develop hepatomegaly and liver failure due to fibrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/94\">",
"     94",
"    </a>",
"    ] Neutropenia and infection rarely are seen [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/94\">",
"     94",
"    </a>",
"    ]. Treatment issues are complex, as children with Down syndrome and either ALL or AMKL are subject to high initial rates of treatment-related mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/97\">",
"     97",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/44/40649?source=see_link&amp;anchor=H6#H6\">",
"     \"Overview of the outcome of acute lymphoblastic leukemia in children\", section on 'Down syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is evidence that these GATA1 mutations are acquired in utero and that finding such mutations at birth might serve as a biomarker for an increased risk of transient leukemia and subsequent AMKL [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/98,99\">",
"     98,99",
"    </a>",
"    ]. In one study, three of four children with DS and AMKL had the same GATA1 mutation in a neonatal blood spot (Guthrie card) that was found at the time of clinical diagnosis of AMKL 12 to 26 months later [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/100\">",
"     100",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Gene expression profiling may help in distinguishing transient leukemia from AMKL [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/101\">",
"     101",
"    </a>",
"    ] and identifying those at risk of progressing from transient leukemia to AMKL [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/102\">",
"     102",
"    </a>",
"    ], as well as distinguishing the AMKL seen in children with DS from AMKL seen in those without DS [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/103\">",
"     103",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Acute lymphoblastic leukemia (ALL)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of developing acute lymphoblastic leukemia (ALL) is approximately 10 to 20 times higher in DS compared with children without DS [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/34,104-106\">",
"     34,104-106",
"    </a>",
"    ] and accounts for 1 to 3 percent of all patients with ALL. The clinical presentation is similar to that in children without DS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/58/4009?source=see_link\">",
"     \"Overview of the presentation and classification of acute lymphoblastic leukemia in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a report comparing ALL in children with and without DS, the following findings were noted at presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/70,104\">",
"     70,104",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Leukocyte count and leukemic cell mass were similar",
"     </li>",
"     <li>",
"      Age distribution and immunophenotype were similar",
"     </li>",
"     <li>",
"      Clinically they were indistinguishable [",
"      <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/71\">",
"       71",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Mediastinal mass (1.6 versus 8.9 percent) and CNS leukemia (0 versus 2.7 percent) were less common in DS, both favorable prognostic signs",
"     </li>",
"     <li>",
"      Less T-cell leukemia or translocation of (9;22) or t(4;11) were seen in DS, both unfavorable prognostic signs",
"     </li>",
"     <li>",
"      Cytogenetic differences occurred, including less hyperdiploidy in DS, an unfavorable prognostic sign",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Children with DS who develop ALL often respond to chemotherapy, similar to children without DS. The treatment and outcome for children with DS and ALL are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/44/40649?source=see_link&amp;anchor=H6#H6\">",
"     \"Overview of the outcome of acute lymphoblastic leukemia in children\", section on 'Down syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5936278\">",
"    <span class=\"h1\">",
"     PULMONARY DISORDERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sixty percent of 208 children with DS in a 2004 survey were reported by their parents to have respiratory conditions, including sleep apnea and asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/107\">",
"     107",
"    </a>",
"    ], although this may be an underestimate based upon results from other studies [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/108\">",
"     108",
"    </a>",
"    ]. Other pulmonary complications that are more common in children with DS include disorders of the pulmonary vasculature, parenchymal lung disease, upper and lower airway abnormalities, and chronic aspiration [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/109\">",
"     109",
"    </a>",
"    ]. Respiratory tract infections are also more frequent and often more severe than in children without DS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2688733\">",
"    <span class=\"h2\">",
"     Sleep apnea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obstructive sleep apnea occurs in at least 30 to 75 percent of children with DS, including those who are not obese [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/108,110-115\">",
"     108,110-115",
"    </a>",
"    ]. In a population of 65 unselected 3.5-year-olds with DS, polysomnograms were classified as abnormal with evidence of obstructive sleep apnea in 57 percent. Among the 45 children whose parents reported no sleep problems, 54 percent had abnormal results [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/108\">",
"     108",
"    </a>",
"    ]. The mechanism includes soft tissue and skeletal alterations that lead to upper airway obstruction. Intermittent hypoxemia may lead to pulmonary hypertension and contribute to mental impairment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/36/9801?source=see_link\">",
"     \"Mechanisms and predisposing factors for sleep related breathing disorders in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2688998\">",
"    <span class=\"h1\">",
"     SKIN DISORDERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of DS children have associated skin disorders, which are considered benign [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/116-118\">",
"     116-118",
"    </a>",
"    ]. In one series, 62 of 71 children (87 percent) had skin abnormalities in the following proportions [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/119\">",
"     119",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Palmoplantar hyperkeratosis &mdash; 41 percent",
"     </li>",
"     <li>",
"      Seborrheic dermatitis &mdash; 31 percent",
"     </li>",
"     <li>",
"      Fissured tongue &mdash; 20 percent",
"     </li>",
"     <li>",
"      Cutis marmorata &mdash; 13 percent",
"     </li>",
"     <li>",
"      Geographic tongue &mdash; 11 percent",
"     </li>",
"     <li>",
"      Xerosis &mdash; 10 percent",
"     </li>",
"     <li>",
"      Alopecia areata &mdash; 8 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/116,117\">",
"       116,117",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In adolescents, dermatologic problems become particularly bothersome. The most common condition in this age group is folliculitis, which affects 50 to 60 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/120\">",
"     120",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     REPRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with DS are fertile and may become pregnant. In one series, 30 pregnancies in 26 women resulted in 10 offspring with DS, 18 (including one set of twins) without DS, and three spontaneous abortions [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/121\">",
"     121",
"    </a>",
"    ]. Appropriate counseling should be provided for management of menstruation and contraception [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/122\">",
"     122",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nearly all males with DS are infertile. The mechanism is impairment of spermatogenesis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/123\">",
"     123",
"    </a>",
"    ]. However, cases have been reported of offspring from fathers with DS [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/124,125\">",
"     124,125",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12592131\">",
"    <span class=\"h1\">",
"     UROLOGIC ABNORMALITIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies suggest an increased incidence of urologic abnormalities in individuals with DS. These include hypospadias (1 in 250 males), cryptorchidism (14 to 27 percent of males), testicular cancer, and renal malformations (3.5 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/126\">",
"     126",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/42/26280?source=see_link\">",
"     \"Hypospadias\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/44/17098?source=see_link\">",
"     \"Undescended testes (cryptorchidism) in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/47/41720?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and staging of testicular germ cell tumors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/60/22472?source=see_link\">",
"     \"Overview of congenital anomalies of the kidney and urinary tract (CAKUT)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     ATLANTOAXIAL INSTABILITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atlantoaxial instability (AAI), defined as excessive mobility of the articulation of the atlas (C1) and the axis (C2), may lead to subluxation of the cervical spine [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/127\">",
"     127",
"    </a>",
"    ]. Approximately 13 percent of individuals with DS have asymptomatic AAI, while spinal cord compression due to the disorder affects approximately 2 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/128\">",
"     128",
"    </a>",
"    ]. The diagnosis is made by lateral neck radiographs taken in neutral position, flexion, and extension.",
"   </p>",
"   <p>",
"    Patients with symptomatic spinal cord compression may have neck pain, torticollis, gait abnormalities, loss of bowel or bladder control, or signs of quadriparesis or quadriplegia, and require immediate stabilization. Asymptomatic individuals appear to remain asymptomatic whether or not physical activity is restricted [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/129,130\">",
"     129,130",
"    </a>",
"    ]. In one study, DS children with AAI were randomly assigned to participate or not in athletic activities considered to be risky and evaluated after one year. The groups were similar in motor function, frequency of neurologic signs, and changes in atlantoaxial distance, and were also similar to children with DS and without AAI [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/129\">",
"     129",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     ARTHROPATHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Down syndrome arthropathy has a prevalence of 8 to 10 per 1000 in the general population, or about six times the prevalence of juvenile idiopathic arthritis. In a review of 30 cases, 17 had polyarticular disease at symptom onset, and 13 had oligoarticular disease at symptom onset, but 7 of these progressed to polyarticular disease [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/131\">",
"     131",
"    </a>",
"    ]. Average delay from symptom onset to diagnosis was two years [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/131\">",
"     131",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2689257\">",
"    <span class=\"h1\">",
"     IMMUNE DEFICIENCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;DS is associated with a variety of immunologic impairments that are thought to be related to the increased susceptibility to infection, autoimmune disorders, and malignancies [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/132-136\">",
"     132-136",
"    </a>",
"    ]. Chemotactic defects [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/137\">",
"     137",
"    </a>",
"    ], decreased IgG4 levels [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/138\">",
"     138",
"    </a>",
"    ], and quantitative and qualitative abnormalities of the T cell and B cell systems have been inconsistently demonstrated [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/132-134,139\">",
"     132-134,139",
"    </a>",
"    ]. Whether these represent a primary immune deficiency or early senescence of the immune system is uncertain.",
"   </p>",
"   <p>",
"    Support for an intrinsic immune deficiency is provided by a cross-sectional study, in which immunophenotyping was used to evaluate lymphocyte subpopulations in 96 children with DS who ranged in age from 1 to 20 years [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/140\">",
"     140",
"    </a>",
"    ]. Children with DS had a diminished expansion of T and B cell cells in the first years of life compared with previously published data on healthy children without DS [",
"    <a class=\"abstract\" href=\"UTD.htm?26/15/26874/abstract/141\">",
"     141",
"    </a>",
"    ]. B cells remained diminished (with 88 percent of values below the 10th percentile), although T cells eventually approximated normal levels.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     DIAGNOSIS OF DOWN SYNDROME",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of DS is often made by prenatal screening. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/22/7529?source=see_link\">",
"     \"First trimester combined test and integrated tests for screening for Down syndrome and trisomy 18\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/39/27257?source=see_link\">",
"     \"Laboratory issues related to maternal serum screening for Down syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When no prenatal diagnosis is available, DS is usually recognized from the characteristic phenotypic features present in the newborn (see",
"    <a class=\"local\" href=\"#H2\">",
"     'Dysmorphic features'",
"    </a>",
"    above). Diagnosis should be confirmed with a karyotype performed on a blood sample.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?33/28/34242?source=see_link\">",
"       \"Patient information: Down syndrome (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?28/45/29394?source=see_link\">",
"       \"Patient information: Down syndrome (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12588736\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The characteristic dysmorphic features of Down syndrome predominantly affect the head and neck and the extremities. Ten of the characteristic dysmorphic features are common in newborns with DS and are usually recognized soon after birth. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Dysmorphic features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Almost all individuals with DS have cognitive impairment, although the range is wide. Most are mildly to moderately intellectually disabled, although some are severely impaired. Behavioral and psychiatric disorders are more common in DS than typical children, but less common than in those with other causes of mental retardation. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Intellectual disability (mental retardation)'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Approximately one-half of individuals with DS have congenital heart disease. Septal defects are the most common. Some asymptomatic adolescents and adults without structural heart disease develop valve abnormalities. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Heart disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children with trisomy 21 are at increased risk for gastrointestinal tract anomalies, including duodenal atresia or stenosis, imperforate anus, and esophageal atresia with tracheoesophageal fistula. They are also at increased risk for celiac disease and Hirschsprung disease. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Gastrointestinal abnormalities'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Birth weight, length, and head circumference are less in DS compared with typical infants. The growth rate for height is reduced in DS compared with typical children. In general, weight is less than expected for length in infants with DS, and then increases disproportionally so that the majority of children are obese by age three to four years. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Growth'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ophthalmologic disorders are common in patients with DS and increase in frequency with age. These disorders include refractive errors, strabismus, nystagmus, cataracts, and keratoconus. Hearing loss is also common, and otitis media is a frequent problem. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Eye problems'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13\">",
"       'Hearing loss'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Endocrine abnormalities in DS include thyroid dysfunction and type 1 diabetes. (See",
"      <a class=\"local\" href=\"#H2688495\">",
"       'Endocrine disorders'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hematologic abnormalities affecting red cells, white cells, and platelets are common in DS and include polycythemia, macrocytosis, leukopenia, thrombocytosis, and leukemia (transient, acute megakaryoblastic, and acute lymphoblastic). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Hematologic disorders'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Women with DS are fertile and may become pregnant. However, nearly all males with DS are infertile. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Reproduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Increased rates of urologic abnormalities, arthropathy, pulmonary disease, and benign skin disorders are also seen in patients with DS. (See",
"      <a class=\"local\" href=\"#H12592131\">",
"       'Urologic abnormalities'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H25\">",
"       'Arthropathy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5936278\">",
"       'Pulmonary disorders'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2688998\">",
"       'Skin disorders'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Individuals with DS are at increased risk of atlantoaxial instability (AAI), defined as excessive mobility of the articulation of the atlas (C1) and the axis (C2), although spinal cord compression due to subluxation of the cervical spine is uncommon. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Atlantoaxial instability'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      DS is associated with a variety of immunologic impairments that are thought to be related to the increased susceptibility to infection, autoimmune disorders, and malignancies. However, these defects are inconsistently demonstrated. Whether these represent a primary immune deficiency or early senescence of the immune system is uncertain. (See",
"      <a class=\"local\" href=\"#H2689257\">",
"       'Immune deficiency'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of DS is often made by prenatal screening. DS is otherwise usually recognized from the characteristic phenotypic features present in the newborn. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/22/7529?source=see_link\">",
"       \"First trimester combined test and integrated tests for screening for Down syndrome and trisomy 18\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/39/27257?source=see_link\">",
"       \"Laboratory issues related to maternal serum screening for Down syndrome\"",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H12589040\">",
"       'Neonatal features'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Jones KL. Down syndrome. In: Smith's recognizable patterns of human malformation, 6th ed, Elsevier Saunders, Philadelphia 2006. p.7.",
"    </li>",
"    <li>",
"     Epstein CJ. Down syndrome (Trisomy 21). In: The metabolic and molecular bases of inherited disease, 8th ed, Scriver CR, Beaudet AL, Sly WS, Valle D (Eds), McGraw-Hill, New York 2001. p.1223.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/3\">",
"      Hall B. Mongolism in newborn infants. An examination of the criteria for recognition and some speculations on the pathogenic activity of the chromosomal abnormality. Clin Pediatr (Phila) 1966; 5:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/4\">",
"      Bull MJ, Committee on Genetics. Health supervision for children with Down syndrome. Pediatrics 2011; 128:393.",
"     </a>",
"    </li>",
"    <li>",
"     Winders PC. Gross motor milestone statistics. In: Gross motor skills in children with Down syndrome: A guide for parents and professionals, Woodbine House, Baltimore 1997. p.228.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/6\">",
"      Kumin L. Speech and language skills in children with Down syndrome. MRDD Research Reviews 1996; 2:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/7\">",
"      Brown FR 3rd, Greer MK, Aylward EH, Hunt HH. Intellectual and adaptive functioning in individuals with Down syndrome in relation to age and environmental placement. Pediatrics 1990; 85:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/8\">",
"      Roizen NJ, Patterson D. Down's syndrome. Lancet 2003; 361:1281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/9\">",
"      Lott IT, Dierssen M. Cognitive deficits and associated neurological complications in individuals with Down's syndrome. Lancet Neurol 2010; 9:623.",
"     </a>",
"    </li>",
"    <li>",
"     Miller JF. Profiles of language development in children with Down syndrome. In: Improving the communication of people with Down syndrome, Miller JF, Leddy M, Leavitt LA (Eds), Brookes, Baltimore 1999. p.11.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/11\">",
"      Chapman RS, Seung HK, Schwartz SE, Kay-Raining Bird E. Language skills of children and adolescents with Down syndrome: II. Production deficits. J Speech Lang Hear Res 1998; 41:861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/12\">",
"      Chapman RS, Schwartz SE, Bird EK. Language skills of children and adolescents with Down syndrome: I. Comprehension. J Speech Hear Res 1991; 34:1106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/13\">",
"      Kernan KT. Comprehension of syntactically indicated sequence by Down's syndrome and other mentally retarded adults. J Ment Defic Res 1990; 34 ( Pt 2):169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/14\">",
"      Lai F, Williams RS. A prospective study of Alzheimer disease in Down syndrome. Arch Neurol 1989; 46:849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/15\">",
"      Visser FE, Aldenkamp AP, van Huffelen AC, et al. Prospective study of the prevalence of Alzheimer-type dementia in institutionalized individuals with Down syndrome. Am J Ment Retard 1997; 101:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/16\">",
"      Myers BA, Pueschel SM. Psychiatric disorders in persons with Down syndrome. J Nerv Ment Dis 1991; 179:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/17\">",
"      Kent L, Evans J, Paul M, Sharp M. Comorbidity of autistic spectrum disorders in children with Down syndrome. Dev Med Child Neurol 1999; 41:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/18\">",
"      Rasmussen P, B&ouml;rjesson O, Wentz E, Gillberg C. Autistic disorders in Down syndrome: background factors and clinical correlates. Dev Med Child Neurol 2001; 43:750.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/19\">",
"      Freeman SB, Taft LF, Dooley KJ, et al. Population-based study of congenital heart defects in Down syndrome. Am J Med Genet 1998; 80:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/20\">",
"      Dennis J, Archer N, Ellis J, Marder L. Recognising heart disease in children with Down syndrome. Arch Dis Child Educ Pract Ed 2010; 95:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/21\">",
"      Irving CA, Chaudhari MP. Cardiovascular abnormalities in Down's syndrome: spectrum, management and survival over 22 years. Arch Dis Child 2012; 97:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/22\">",
"      Geggel RL, O'Brien JE, Feingold M. Development of valve dysfunction in adolescents and young adults with Down syndrome and no known congenital heart disease. J Pediatr 1993; 122:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/23\">",
"      Hamada T, Gejyo F, Koshino Y, et al. Echocardiographic evaluation of cardiac valvular abnormalities in adults with Down's syndrome. Tohoku J Exp Med 1998; 185:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/24\">",
"      Fabia J, Drolette M. Malformations and leukemia in children with Down's syndrome. Pediatrics 1970; 45:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/25\">",
"      Moore SW, Johnson AG. Hirschsprung's disease: genetic and functional associations of Down's and Waardenburg syndromes. Semin Pediatr Surg 1998; 7:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/26\">",
"      Sarioglu A, Tanyel FC, B&uuml;y&uuml;kpamuk&ccedil;u N, Hi&ccedil;s&ouml;nmez A. Hirschsprung-associated congenital anomalies. Eur J Pediatr Surg 1997; 7:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/27\">",
"      Menezes M, Puri P. Long-term clinical outcome in patients with Hirschsprung's disease and associated Down's syndrome. J Pediatr Surg 2005; 40:810.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/28\">",
"      Garver KL, Law JC, Garver B. Hirschsprung disease: a genetic study. Clin Genet 1985; 28:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/29\">",
"      Ikeda K, Goto S. Additional anomalies in Hirschsprung's disease: an analysis based on the nationwide survey in Japan. Z Kinderchir 1986; 41:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/30\">",
"      Carlsson AK, Axelsson IE, Borulf SK, et al. Serological screening for celiac disease in healthy 2.5-year-old children in Sweden. Pediatrics 2001; 107:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/31\">",
"      Book L, Hart A, Black J, et al. Prevalence and clinical characteristics of celiac disease in Downs syndrome in a US study. Am J Med Genet 2001; 98:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/32\">",
"      Zachor DA, Mroczek-Musulman E, Brown P. Prevalence of celiac disease in Down syndrome in the United States. J Pediatr Gastroenterol Nutr 2000; 31:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/33\">",
"      M&auml;ki M, Mustalahti K, Kokkonen J, et al. Prevalence of Celiac disease among children in Finland. N Engl J Med 2003; 348:2517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/34\">",
"      Goldacre MJ, Wotton CJ, Seagroatt V, Yeates D. Cancers and immune related diseases associated with Down's syndrome: a record linkage study. Arch Dis Child 2004; 89:1014.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/35\">",
"      Pueschel SM, Rothman KJ, Ogilby JD. Birth weight of children with Down's syndrome. Am J Ment Defic 1976; 80:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/36\">",
"      Cronk CE. Growth of children with Down's syndrome: birth to age 3 years. Pediatrics 1978; 61:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/37\">",
"      Toledo C, Alembik Y, Aguirre Jaime A, Stoll C. Growth curves of children with Down syndrome. Ann Genet 1999; 42:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/38\">",
"      Cronk C, Crocker AC, Pueschel SM, et al. Growth charts for children with Down syndrome: 1 month to 18 years of age. Pediatrics 1988; 81:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/39\">",
"      Rubin SS, Rimmer JH, Chicoine B, et al. Overweight prevalence in persons with Down syndrome. Ment Retard 1998; 36:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/40\">",
"      Palmer CG, Cronk C, Pueschel SM, et al. Head circumference of children with Down syndrome (0-36 months). Am J Med Genet 1992; 42:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/41\">",
"      Piro E, Pennino C, Cammarata M, et al. Growth charts of Down syndrome in Sicily: evaluation of 382 children 0-14 years of age. Am J Med Genet Suppl 1990; 7:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/42\">",
"      Cremers MJ, van der Tweel I, Boersma B, et al. Growth curves of Dutch children with Down's syndrome. J Intellect Disabil Res 1996; 40 ( Pt 5):412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/43\">",
"      Myrelid A, Gustafsson J, Ollars B, Anner&eacute;n G. Growth charts for Down's syndrome from birth to 18 years of age. Arch Dis Child 2002; 87:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/44\">",
"      Anner&eacute;n G, Gustavson KH, Sara VR, Tuvemo T. Growth retardation in Down syndrome in relation to insulin-like growth factors and growth hormone. Am J Med Genet Suppl 1990; 7:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/45\">",
"      Torrado C, Bastian W, Wisniewski KE, Castells S. Treatment of children with Down syndrome and growth retardation with recombinant human growth hormone. J Pediatr 1991; 119:478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/46\">",
"      Milunsky A, Lowy C, Rubenstein AH, Wright AD. Carbohydrate tolerance, growth hormone and insulin levels in mongolism. Dev Med Child Neurol 1968; 10:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/47\">",
"      Anner&eacute;n G, Sara VR, Hall K, Tuvemo T. Growth and somatomedin responses to growth hormone in Down's syndrome. Arch Dis Child 1986; 61:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/48\">",
"      Castells S, Beaulieu I, Torrado C, et al. Hypothalamic versus pituitary dysfunction in Down's syndrome as cause of growth retardation. J Intellect Disabil Res 1996; 40 ( Pt 6):509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/49\">",
"      Sara VR, Gustavson KH, Anner&eacute;n G, et al. Somatomedins in Down's syndrome. Biol Psychiatry 1983; 18:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/50\">",
"      Sara VR, Sj&ouml;gren B, Anner&eacute;n G, et al. The presence of normal receptors for somatomedin and insulin in fetuses with Down's syndrome. Biol Psychiatry 1984; 19:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/51\">",
"      Allison DB, Gomez JE, Heshka S, et al. Decreased resting metabolic rate among persons with Down Syndrome. Int J Obes Relat Metab Disord 1995; 19:858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/52\">",
"      Luke A, Roizen NJ, Sutton M, Schoeller DA. Energy expenditure in children with Down syndrome: correcting metabolic rate for movement. J Pediatr 1994; 125:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/53\">",
"      Roizen NJ, Mets MB, Blondis TA. Ophthalmic disorders in children with Down syndrome. Dev Med Child Neurol 1994; 36:594.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/54\">",
"      Shapiro MB, France TD. The ocular features of Down's syndrome. Am J Ophthalmol 1985; 99:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/55\">",
"      Caputo AR, Wagner RS, Reynolds DR, et al. Down syndrome. Clinical review of ocular features. Clin Pediatr (Phila) 1989; 28:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/56\">",
"      Kim JH, Hwang JM, Kim HJ, Yu YS. Characteristic ocular findings in Asian children with Down syndrome. Eye (Lond) 2002; 16:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/57\">",
"      Creavin AL, Brown RD. Ophthalmic abnormalities in children with Down syndrome. J Pediatr Ophthalmol Strabismus 2009; 46:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/58\">",
"      Hestnes A, Sand T, Fostad K. Ocular findings in Down's syndrome. J Ment Defic Res 1991; 35 ( Pt 3):194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/59\">",
"      Shott SR, Joseph A, Heithaus D. Hearing loss in children with Down syndrome. Int J Pediatr Otorhinolaryngol 2001; 61:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/60\">",
"      Roizen NJ, Wolters C, Nicol T, Blondis TA. Hearing loss in children with Down syndrome. J Pediatr 1993; 123:S9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/61\">",
"      Park AH, Wilson MA, Stevens PT, et al. Identification of hearing loss in pediatric patients with Down syndrome. Otolaryngol Head Neck Surg 2012; 146:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/62\">",
"      Karlsson B, Gustafsson J, Hedov G, et al. Thyroid dysfunction in Down's syndrome: relation to age and thyroid autoimmunity. Arch Dis Child 1998; 79:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/63\">",
"      Sare Z, Ruvalcaba RH, Kelley VC. Prevalence of thyroid disorder in Down syndrome. Clin Genet 1978; 14:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/64\">",
"      T&uuml;ys&uuml;z B, Beker DB. Thyroid dysfunction in children with Down's syndrome. Acta Paediatr 2001; 90:1389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/65\">",
"      van Trotsenburg AS, Vulsma T, van Santen HM, et al. Lower neonatal screening thyroxine concentrations in down syndrome newborns. J Clin Endocrinol Metab 2003; 88:1512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/66\">",
"      Meyerovitch J, Antebi F, Greenberg-Dotan S, et al. Hyperthyrotropinaemia in untreated subjects with Down's syndrome aged 6 months to 64 years: a comparative analysis. Arch Dis Child 2012; 97:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/67\">",
"      Anwar AJ, Walker JD, Frier BM. Type 1 diabetes mellitus and Down's syndrome: prevalence, management and diabetic complications. Diabet Med 1998; 15:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/68\">",
"      Van Goor JC, Massa GG, Hirasing R. Increased incidence and prevalence of diabetes mellitus in Down's syndrome. Arch Dis Child 1997; 77:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/69\">",
"      Ruwaard D, Hirasing RA, Reeser HM, et al. Increasing incidence of type I diabetes in The Netherlands. The second nationwide study among children under 20 years of age. Diabetes Care 1994; 17:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/70\">",
"      Lange B. The management of neoplastic disorders of haematopoiesis in children with Down's syndrome. Br J Haematol 2000; 110:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/71\">",
"      Malinge S, Izraeli S, Crispino JD. Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome. Blood 2009; 113:2619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/72\">",
"      Kivivuori SM, Rajantie J, Siimes MA. Peripheral blood cell counts in infants with Down's syndrome. Clin Genet 1996; 49:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/73\">",
"      Widness JA, Pueschel SM, Pezzullo JC, Clemons GK. Elevated erythropoietin levels in cord blood of newborns with Down's syndrome. Biol Neonate 1994; 66:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/74\">",
"      Roizen NJ, Amarose AP. Hematologic abnormalities in children with Down syndrome. Am J Med Genet 1993; 46:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/75\">",
"      Carpenter E, Valverde-Garduno V, Sternberg A, et al. GATA1 mutation and trisomy 21 are required only in haematopoietic cells for development of transient myeloproliferative disorder. Br J Haematol 2005; 128:548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/76\">",
"      Massey GV, Zipursky A, Chang MN, et al. A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481. Blood 2006; 107:4606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/77\">",
"      Klusmann JH, Creutzig U, Zimmermann M, et al. Treatment and prognostic impact of transient leukemia in neonates with Down syndrome. Blood 2008; 111:2991.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/78\">",
"      Zipursky A. Transient leukaemia--a benign form of leukaemia in newborn infants with trisomy 21. Br J Haematol 2003; 120:930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/79\">",
"      Dormann S, Kr&uuml;ger M, Hentschel R, et al. Life-threatening complications of transient abnormal myelopoiesis in neonates with Down syndrome. Eur J Pediatr 2004; 163:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/80\">",
"      Webb DK. Optimizing therapy for myeloid disorders of Down syndrome. Br J Haematol 2005; 131:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/81\">",
"      Shivdasani RA. Molecular and transcriptional regulation of megakaryocyte differentiation. Stem Cells 2001; 19:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/82\">",
"      Izraeli S. Leukaemia -- a developmental perspective. Br J Haematol 2004; 126:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/83\">",
"      Hitzler JK, Zipursky A. Origins of leukaemia in children with Down syndrome. Nat Rev Cancer 2005; 5:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/84\">",
"      Mundschau G, Gurbuxani S, Gamis AS, et al. Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis. Blood 2003; 101:4298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/85\">",
"      Hitzler JK, Cheung J, Li Y, et al. GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome. Blood 2003; 101:4301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/86\">",
"      Alford KA, Reinhardt K, Garnett C, et al. Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia. Blood 2011; 118:2222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/87\">",
"      Hayashi Y, Eguchi M, Sugita K, et al. Cytogenetic findings and clinical features in acute leukemia and transient myeloproliferative disorder in Down's syndrome. Blood 1988; 72:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/88\">",
"      Nijhawan A, Baselga E, Gonzalez-Ensenat MA, et al. Vesiculopustular eruptions in Down syndrome neonates with myeloproliferative disorders. Arch Dermatol 2001; 137:760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/89\">",
"      Burch JM, Weston WL, Rogers M, Morelli JG. Cutaneous pustular leukemoid reactions in trisomy 21. Pediatr Dermatol 2003; 20:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/90\">",
"      Al-Kasim F, Doyle JJ, Massey GV, et al. Incidence and treatment of potentially lethal diseases in transient leukemia of Down syndrome: Pediatric Oncology Group Study. J Pediatr Hematol Oncol 2002; 24:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/91\">",
"      Muramatsu H, Kato K, Watanabe N, et al. Risk factors for early death in neonates with Down syndrome and transient leukaemia. Br J Haematol 2008; 142:610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/92\">",
"      Miyauchi J, Ito Y, Kawano T, et al. Unusual diffuse liver fibrosis accompanying transient myeloproliferative disorder in Down's syndrome: a report of four autopsy cases and proposal of a hypothesis. Blood 1992; 80:1521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/93\">",
"      Hattori H, Matsuzaki A, Suminoe A, et al. High expression of platelet-derived growth factor and transforming growth factor-beta 1 in blast cells from patients with Down Syndrome suffering from transient myeloproliferative disorder and organ fibrosis. Br J Haematol 2001; 115:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/94\">",
"      Zipursky A, Rose T, Skidmore M, et al. Hydrops fetalis and neonatal leukemia in Down syndrome. Pediatr Hematol Oncol 1996; 13:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/95\">",
"      Gamis AS, Alonzo TA, Gerbing RB, et al. Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971. Blood 2011; 118:6752.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/96\">",
"      Zipursky A, Peeters M, Poon A. Megakaryoblastic leukemia and Down's syndrome: a review. Pediatr Hematol Oncol 1987; 4:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/97\">",
"      Rao A, Hills RK, Stiller C, et al. Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trials. Br J Haematol 2006; 132:576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/98\">",
"      Taub JW, Mundschau G, Ge Y, et al. Prenatal origin of GATA1 mutations may be an initiating step in the development of megakaryocytic leukemia in Down syndrome. Blood 2004; 104:1588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/99\">",
"      Pine SR, Guo Q, Yin C, et al. Incidence and clinical implications of GATA1 mutations in newborns with Down syndrome. Blood 2007; 110:2128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/100\">",
"      Ahmed M, Sternberg A, Hall G, et al. Natural history of GATA1 mutations in Down syndrome. Blood 2004; 103:2480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/101\">",
"      McElwaine S, Mulligan C, Groet J, et al. Microarray transcript profiling distinguishes the transient from the acute type of megakaryoblastic leukaemia (M7) in Down's syndrome, revealing PRAME as a specific discriminating marker. Br J Haematol 2004; 125:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/102\">",
"      Kanezaki R, Toki T, Terui K, et al. Down syndrome and GATA1 mutations in transient abnormal myeloproliferative disorder: mutation classes correlate with progression to myeloid leukemia. Blood 2010; 116:4631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/103\">",
"      Bourquin JP, Subramanian A, Langebrake C, et al. Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling. Proc Natl Acad Sci U S A 2006; 103:3339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/104\">",
"      D&ouml;rdelmann M, Schrappe M, Reiter A, et al. Down's syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials. Berlin-Frankfurt-M&uuml;nster Group. Leukemia 1998; 12:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/105\">",
"      Hasle H, Clemmensen IH, Mikkelsen M. Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet 2000; 355:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/106\">",
"      Whitlock JA. Down syndrome and acute lymphoblastic leukaemia. Br J Haematol 2006; 135:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/107\">",
"      Thomas K, Bourke J, Girdler S, et al. Variation over time in medical conditions and health service utilization of children with Down syndrome. J Pediatr 2011; 158:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/108\">",
"      Shott SR, Amin R, Chini B, et al. Obstructive sleep apnea: Should all children with Down syndrome be tested? Arch Otolaryngol Head Neck Surg 2006; 132:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/109\">",
"      McDowell KM, Craven DI. Pulmonary complications of Down syndrome during childhood. J Pediatr 2011; 158:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/110\">",
"      Marcus CL, Keens TG, Bautista DB, et al. Obstructive sleep apnea in children with Down syndrome. Pediatrics 1991; 88:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/111\">",
"      Stebbens VA, Dennis J, Samuels MP, et al. Sleep related upper airway obstruction in a cohort with Down's syndrome. Arch Dis Child 1991; 66:1333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/112\">",
"      Southall DP, Stebbens VA, Mirza R, et al. Upper airway obstruction with hypoxaemia and sleep disruption in Down syndrome. Dev Med Child Neurol 1987; 29:734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/113\">",
"      Levanon A, Tarasiuk A, Tal A. Sleep characteristics in children with Down syndrome. J Pediatr 1999; 134:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/114\">",
"      Dyken ME, Lin-Dyken DC, Poulton S, et al. Prospective polysomnographic analysis of obstructive sleep apnea in down syndrome. Arch Pediatr Adolesc Med 2003; 157:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/115\">",
"      Fitzgerald DA, Paul A, Richmond C. Severity of obstructive apnoea in children with Down syndrome who snore. Arch Dis Child 2007; 92:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/116\">",
"      Barankin B, Guenther L. Dermatological manifestations of Down's syndrome. J Cutan Med Surg 2001; 5:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/117\">",
"      Madan V, Williams J, Lear JT. Dermatological manifestations of Down's syndrome. Clin Exp Dermatol 2006; 31:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/118\">",
"      Daneshpazhooh M, Nazemi TM, Bigdeloo L, Yoosefi M. Mucocutaneous findings in 100 children with Down syndrome. Pediatr Dermatol 2007; 24:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/119\">",
"      Ercis M, Balci S, Atakan N. Dermatological manifestations of 71 Down syndrome children admitted to a clinical genetics unit. Clin Genet 1996; 50:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/120\">",
"      Pueschel SM. Clinical aspects of Down syndrome from infancy to adulthood. Am J Med Genet Suppl 1990; 7:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/121\">",
"      Bovicelli L, Orsini LF, Rizzo N, et al. Reproduction in Down syndrome. Obstet Gynecol 1982; 59:13S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/122\">",
"      American Academy of Pediatrics. Committee on Genetics. American Academy of Pediatrics: Health supervision for children with Down syndrome. Pediatrics 2001; 107:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/123\">",
"      Johannisson R, Gropp A, Winking H, et al. Down's syndrome in the male. Reproductive pathology and meiotic studies. Hum Genet 1983; 63:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/124\">",
"      Z&uuml;hlke C, Thies U, Braulke I, et al. Down syndrome and male fertility: PCR-derived fingerprinting, serological and andrological investigations. Clin Genet 1994; 46:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/125\">",
"      Sheridan R, Llerena J Jr, Matkins S, et al. Fertility in a male with trisomy 21. J Med Genet 1989; 26:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/126\">",
"      Mercer ES, Broecker B, Smith EA, et al. Urological manifestations of Down syndrome. J Urol 2004; 171:1250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/127\">",
"      Cohen WI. Atlantoaxial instability. What's next? Arch Pediatr Adolesc Med 1998; 152:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/128\">",
"      Pueschel SM, Scola FH. Atlantoaxial instability in individuals with Down syndrome: epidemiologic, radiographic, and clinical studies. Pediatrics 1987; 80:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/129\">",
"      Cremers MJ, Bol E, de Roos F, van Gijn J. Risk of sports activities in children with Down's syndrome and atlantoaxial instability. Lancet 1993; 342:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/130\">",
"      Pueschel SM, Scola FH, Pezzullo JC. A longitudinal study of atlanto-dens relationships in asymptomatic individuals with Down syndrome. Pediatrics 1992; 89:1194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/131\">",
"      Juj H, Emery H. The arthropathy of Down syndrome: an underdiagnosed and under-recognized condition. J Pediatr 2009; 154:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/132\">",
"      Ugazio AG, Maccario R, Notarangelo LD, Burgio GR. Immunology of Down syndrome: a review. Am J Med Genet Suppl 1990; 7:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/133\">",
"      Nespoli L, Burgio GR, Ugazio AG, Maccario R. Immunological features of Down's syndrome: a review. J Intellect Disabil Res 1993; 37 ( Pt 6):543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/134\">",
"      Cuadrado E, Barrena MJ. Immune dysfunction in Down's syndrome: primary immune deficiency or early senescence of the immune system? Clin Immunol Immunopathol 1996; 78:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/135\">",
"      Bloemers BL, van Bleek GM, Kimpen JL, Bont L. Distinct abnormalities in the innate immune system of children with Down syndrome. J Pediatr 2010; 156:804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/136\">",
"      Ram G, Chinen J. Infections and immunodeficiency in Down syndrome. Clin Exp Immunol 2011; 164:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/137\">",
"      Novo E, Garc&iacute;a MI, Lavergne J. Nonspecific immunity in Down syndrome: a study of chemotaxis, phagocytosis, oxidative metabolism, and cell surface marker expression of polymorphonuclear cells. Am J Med Genet 1993; 46:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/138\">",
"      Anner&eacute;n G, Magnusson CG, Lilja G, Nordvall SL. Abnormal serum IgG subclass pattern in children with Down's syndrome. Arch Dis Child 1992; 67:628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/139\">",
"      Berman S, Lee B, Nuss R, et al. Immunoglobulin G, total and subclass, in children with or without recurrent otitis media. J Pediatr 1992; 121:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/140\">",
"      de Hingh YC, van der Vossen PW, Gemen EF, et al. Intrinsic abnormalities of lymphocyte counts in children with down syndrome. J Pediatr 2005; 147:744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/15/26874/abstract/141\">",
"      Comans-Bitter WM, de Groot R, van den Beemd R, et al. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr 1997; 130:388.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2917 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-983B24DA49-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_15_26874=[""].join("\n");
var outline_f26_15_26874=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12588736\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DYSMORPHIC FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Head and neck",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Extremities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12589040\">",
"      Neonatal features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      INTELLECTUAL DISABILITY (MENTAL RETARDATION)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31550131\">",
"      Dementia/Alzheimer disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2688065\">",
"      Behavioral and psychiatric disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      HEART DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      GASTROINTESTINAL ABNORMALITIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      GROWTH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Short stature",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Obesity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      EYE PROBLEMS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      HEARING LOSS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2688495\">",
"      ENDOCRINE DISORDERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2688520\">",
"      Thyroid disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2688527\">",
"      Diabetes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      HEMATOLOGIC DISORDERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Transient leukemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Acute megakaryoblastic leukemia (AMKL)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Acute lymphoblastic leukemia (ALL)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5936278\">",
"      PULMONARY DISORDERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2688733\">",
"      Sleep apnea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2688998\">",
"      SKIN DISORDERS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      REPRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12592131\">",
"      UROLOGIC ABNORMALITIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      ATLANTOAXIAL INSTABILITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      ARTHROPATHY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2689257\">",
"      IMMUNE DEFICIENCY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      DIAGNOSIS OF DOWN SYNDROME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12588736\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/2917\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/2917|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/15/11505\" title=\"picture 1\">",
"      Down syndrome facies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?26/22/26991\" title=\"picture 2\">",
"      Transverse palmar crease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/34/42543\" title=\"picture 3\">",
"      Hypotonia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/63/32761?source=related_link\">",
"      Adult attention deficit hyperactivity disorder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/55/18293?source=related_link\">",
"      Annular pancreas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/18/26922?source=related_link\">",
"      Attention deficit hyperactivity disorder in children and adolescents: Clinical features and evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/14/22761?source=related_link\">",
"      Cataract in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26201?source=related_link\">",
"      Classification and clinical features of isolated atrial septal defects in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/50/39720?source=related_link\">",
"      Classification of acute myeloid leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/41/664?source=related_link\">",
"      Clinical features of autism spectrum disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/3/37946?source=related_link\">",
"      Clinical manifestations and diagnosis of celiac disease in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/13/11481?source=related_link\">",
"      Clinical manifestations and diagnosis of depression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/52/35656?source=related_link\">",
"      Clinical manifestations and diagnosis of patent ductus arteriosus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/47/41720?source=related_link\">",
"      Clinical manifestations, diagnosis, and staging of testicular germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41848?source=related_link\">",
"      Congenital aganglionic megacolon (Hirschsprung disease)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/27/29114?source=related_link\">",
"      Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/0/23562?source=related_link\">",
"      Congenital cytogenetic abnormalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/10/5289?source=related_link\">",
"      Depression in adolescents: Epidemiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/29/19928?source=related_link\">",
"      Developmental and behavioral screening tests in primary care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/25/28057?source=related_link\">",
"      Evaluation of cognitive impairment and dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/22/7529?source=related_link\">",
"      First trimester combined test and integrated tests for screening for Down syndrome and trisomy 18",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/42/26280?source=related_link\">",
"      Hypospadias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/10/26793?source=related_link\">",
"      Intellectual disability (mental retardation) in children: Definition; causes; and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/55/31608?source=related_link\">",
"      Intestinal atresia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/39/27257?source=related_link\">",
"      Laboratory issues related to maternal serum screening for Down syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/16/21767?source=related_link\">",
"      Macrocytosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/58/13224?source=related_link\">",
"      Management of Down syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/36/9801?source=related_link\">",
"      Mechanisms and predisposing factors for sleep related breathing disorders in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/6/36968?source=related_link\">",
"      Neonatal polycythemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/60/22472?source=related_link\">",
"      Overview of congenital anomalies of the kidney and urinary tract (CAKUT)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/31/41463?source=related_link\">",
"      Overview of glaucoma in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/27/22969?source=related_link\">",
"      Overview of prenatal screening and diagnosis of Down syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/44/40649?source=related_link\">",
"      Overview of the outcome of acute lymphoblastic leukemia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/58/4009?source=related_link\">",
"      Overview of the presentation and classification of acute lymphoblastic leukemia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/19/8506?source=related_link\">",
"      Pathophysiology and clinical features of isolated ventricular septal defects in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/27/13752?source=related_link\">",
"      Pathophysiology, clinical features, and diagnosis of tetralogy of Fallot",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/45/29394?source=related_link\">",
"      Patient information: Down syndrome (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?33/28/34242?source=related_link\">",
"      Patient information: Down syndrome (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/62/34793?source=related_link\">",
"      Prenatal diagnosis of gastrointestinal atresia and obstruction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/44/17098?source=related_link\">",
"      Undescended testes (cryptorchidism) in children and adolescents",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_15_26875="Diagnostic tests in GUD";
var content_f26_15_26875=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F77961&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F77961&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diagnostic tests for infectious causes of genital ulcer disease",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       GUD syndrome",
"      </td>",
"      <td class=\"subtitle1\">",
"       Diagnostic findings",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"4\">",
"       HSV",
"      </td>",
"      <td>",
"       HSV culture",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Polymerase chain reaction",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Direct fluorescent antibody",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Tzanck preparation: multinucleated giant cells (low sensitivity)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"2\">",
"       Syphilis",
"      </td>",
"      <td>",
"       Serology positive in 60-90 percent of patients with primary lesions",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Darkfield reveals typical \"corkscrew\" appearance of spirochete",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"2\">",
"       Chancroid",
"      </td>",
"      <td>",
"       Small gram negative rods in parallel alignment on Gram stain (\"school of fish\")",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Positive culture using specialized media",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Lymphogranuloma venereum",
"      </td>",
"      <td>",
"       Serology positive (cannot distinguish Chlamydia species)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"2\">",
"       Granuloma inguinale",
"      </td>",
"      <td>",
"       Donovan bodies in macrophages on biopsy or tissue crush preparation",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cannot be cultured",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_15_26875=[""].join("\n");
var outline_f26_15_26875=null;
var title_f26_15_26876="Noninfectious causes of RD";
var content_f26_15_26876=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F56457&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F56457&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Noninfectious causes of neonatal respiratory distress",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Anatomic/development defects",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Primary pulmonary hypoplasia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Cystic adenomatoid malformation",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Tracheoesophageal fistula",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Diaphragmatic hernia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Congenital heart disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Choanal atresia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Tracheal web",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Laryngotracheomalacia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            External compression of the trachea (eg, goiter)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Central nervous system malformation",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hydrocephalus",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Genetic (eg, immotile cilia syndrome, surfactant protein B deficiency, urea cycle defect)",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Physiologic/pathologic disorders",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Transient tachypnea of the newborn",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Respiratory distress syndrome",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Meconium aspiration pneumonia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pulmonary hemorrhage",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pulmonary edema",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pneumothorax",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hydrothorax/chylothorax",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Aspiration pneumonia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hypoglycemia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Metabolic acidosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Respiratory alkalosis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Central nervous system injury",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_15_26876=[""].join("\n");
var outline_f26_15_26876=null;
var title_f26_15_26877="Recurring karyotypic abnormalities in AML";
var content_f26_15_26877=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F70905&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F70905&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Recurring karyotypic abnormalities in acute myeloid leukemia (AML)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Cytogenic abnormality&nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Morphology",
"       </td>",
"       <td class=\"subtitle1\">",
"        Affected genes",
"       </td>",
"       <td class=\"subtitle1\">",
"        Median age (yrs)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Approximate incidence in De Novo AML",
"       </td>",
"       <td class=\"subtitle1\">",
"        Prognostic effects",
"       </td>",
"       <td class=\"subtitle1\">",
"        Comments",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        t(8;21)",
"       </td>",
"       <td>",
"        M2",
"       </td>",
"       <td>",
"        AML1/ETO",
"       </td>",
"       <td>",
"        30",
"       </td>",
"       <td>",
"        5 to 7 percent",
"       </td>",
"       <td>",
"        Favorable",
"       </td>",
"       <td>",
"        Auer rods usually present",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        t(15;17)",
"       </td>",
"       <td>",
"        M3",
"       </td>",
"       <td>",
"        PML-RAR&alpha;",
"       </td>",
"       <td>",
"        40",
"       </td>",
"       <td>",
"        5 to 8 percent",
"       </td>",
"       <td>",
"        Favorable-high cure rate with ATRA-based therapy",
"       </td>",
"       <td>",
"        DIC",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        t(11;17)",
"       </td>",
"       <td>",
"        Similar to M3",
"       </td>",
"       <td>",
"        PLZF/ RAR&alpha;",
"       </td>",
"       <td>",
"        ?",
"       </td>",
"       <td>",
"        &lt;1 percent",
"       </td>",
"       <td>",
"        Poor response to ATRA-based therapy",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        abn16q22",
"       </td>",
"       <td>",
"        M4 with eosinophilia",
"       </td>",
"       <td>",
"        CBFA/MYH11",
"       </td>",
"       <td>",
"        35 to 40",
"       </td>",
"       <td>",
"        5 percent",
"       </td>",
"       <td>",
"        Favorable",
"       </td>",
"       <td>",
"        High reinduction rate post relapse",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        abn11q23",
"       </td>",
"       <td>",
"        M5",
"       </td>",
"       <td>",
"        MLL + many partners",
"       </td>",
"       <td>",
"        &gt;50",
"       </td>",
"       <td>",
"        3 percent",
"       </td>",
"       <td>",
"        Poor except t(9;11)",
"       </td>",
"       <td>",
"        Hyperleukocytosis, extra medullary disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        +8",
"       </td>",
"       <td>",
"        Varied",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &gt;60",
"       </td>",
"       <td>",
"        5 to 10 percent",
"       </td>",
"       <td>",
"        Poor",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        del 5, del 7, 5q-, 7q-, or combinations",
"       </td>",
"       <td>",
"        Varied; common in FAB M6",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &gt;60",
"       </td>",
"       <td>",
"        15 to 20 percent",
"       </td>",
"       <td>",
"        Poor",
"       </td>",
"       <td>",
"        Common in patients with secondary AML, prior MDS -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Inv 3",
"       </td>",
"       <td>",
"        Abnormal megakaryocytes",
"       </td>",
"       <td>",
"        Ribophorin/EVI1",
"       </td>",
"       <td>",
"        ?",
"       </td>",
"       <td>",
"        &lt;1 percent",
"       </td>",
"       <td>",
"        Poor",
"       </td>",
"       <td>",
"        Increased platelet count; other abnor malities common (del 5, del 7)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        +13",
"       </td>",
"       <td>",
"        Varied; sometimes undifferentiated",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Probably &gt;60",
"       </td>",
"       <td>",
"        ~1 to 2 percent",
"       </td>",
"       <td>",
"        Poor",
"       </td>",
"       <td>",
"        Higher frequency of hybrid features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        t(6;9) (p2;q34)",
"       </td>",
"       <td>",
"        M2/M4 with basophilia",
"       </td>",
"       <td>",
"        DEK/CAN",
"       </td>",
"       <td>",
"        ?",
"       </td>",
"       <td>",
"        &lt;1 percent",
"       </td>",
"       <td>",
"        Poor",
"       </td>",
"       <td>",
"        Prominent basophilia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        t(9;22)",
"       </td>",
"       <td>",
"        Usually M1",
"       </td>",
"       <td>",
"        BCR/ABL",
"       </td>",
"       <td>",
"        Probably &gt;50",
"       </td>",
"       <td>",
"        ~1 percent",
"       </td>",
"       <td>",
"        Poor",
"       </td>",
"       <td>",
"        Splenomegaly",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        t(1;22)",
"       </td>",
"       <td>",
"        Often M7",
"       </td>",
"       <td>",
"        MOZ/CBP",
"       </td>",
"       <td>",
"        Infants",
"       </td>",
"       <td>",
"        &lt;1 percent",
"       </td>",
"       <td>",
"        Poor",
"       </td>",
"       <td>",
"        Organomegaly",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        t(8;16)",
"       </td>",
"       <td>",
"        M4,5",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        ?",
"       </td>",
"       <td>",
"        &lt;1 percent",
"       </td>",
"       <td>",
"        Poor",
"       </td>",
"       <td>",
"        Erythrophagocytosis",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     AML: acute myelogenous leukemia; ATRA: all-trans-retinoic acid; DIC: disseminated intravascular coagulation; MDS: myelodysplastic syndrome; CN-AML: cytogenetically normal ; ?: unknown or no association.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Schiffer, CA, Stone, RM. Acute myeloid leukemia and other mast cell neoplasms. In: Cancer Medicine, 8th ed, Hong, WK, Bast, RC Jr, Hait, W, et al. (Eds), People's Medical Publishing House, 2010. Copyright &copy; 2010 PMPH-USA, Ltd.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_15_26877=[""].join("\n");
var outline_f26_15_26877=null;
var title_f26_15_26878="LIP PLH in HIV CXR";
var content_f26_15_26878=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F50817&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F50817&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    LIP/PLH in an HIV-infected 2-year-old boy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 399px; height: 284px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest radiograph showing bilateral reticulonodular interstitial infiltrates. A presumptive diagnosis of lymphoid interstitial pneumonia (LIP) pulmonary lymphoid hyperplasia (PLH) is based upon persistence of characteristic radiographic features for two months or more.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Meg Ferris, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_15_26878=[""].join("\n");
var outline_f26_15_26878=null;
var title_f26_15_26879="HAE prodromal rash";
var content_f26_15_26879=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F79093&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F79093&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    HAE prodromal rash",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 326px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Annular erythematous lesions mimicking chicken-wire appearance.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Yucelten D, Kus S. Chicken-wire erythema, but not urticaria, as the presenting sign of hereditary angioedema. Eur J Dermatol 2006; 16:197. Copyright &copy; 2006 John Libbey Eurotext.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_15_26879=[""].join("\n");
var outline_f26_15_26879=null;
